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Funding Race as Biology: The Relevance 
of “Race” in Medical Research 
Taunya Lovell Banks* 
I. INTRODUCTION: ‘DEM BONES, ‘DEM BONES, ‘DEM 
“BLACK” BONES 
In 1940 the State of North Carolina classified my friend as 
“colored” despite her “white skin, blue eyes, [and] curling blond 
hair.”1 She—like her parents, grandparents, and many other 
black Americans—is often mistaken for white.2 Sixty years 
later when she went for a bone densitometry test—a must for 
postmenopausal women—the technician asked her to fill out a 
form that asked her race. Surprised, she asked why. The 
technician explained that “since the bones of black people are 
different than the bones of white people, the doctor needed this 
information to interpret the scan correctly.”3 
The radiologist who analyzed my friend’s bone scan 
acknowledged that there is a debate within the radiology 
© 2011 by Taunya Lovell Banks. 
*Jacob A. France Professor of Equality Jurisprudence, University of Maryland 
School of Law. Thanks to Jonathan Kahn, Leslie Meltzer Henry, Amanda 
Pustilnik and Judy Scales-Trent for their helpful comments on earlier versions 
of this article, and to Erin Doran class of 2011 and Susan McCarty for their 
research and editorial assistance. 
 1. Judy Scales-Trent, Bones Essay 1 (Nov. 7, 2008) (unpublished 
manuscript) (on file with author). In 1940 under the North Carolina State 
Constitution and the state anti-miscegenation statute a “negro” or “person of 
negro descent” was someone “of negro descent to the third generation, 
inclusive,” in other words, a “person who has one-eighth [or more] negro blood 
in his veins.” State v. Miller, 29 S.E.2d 751, 752 (N.C. 1944). See also N.C. 
CONST. art. XIV, § 8 (unenforceable in 1967); N.C. GEN. STAT. § 51-3 (1943). 
 2. See generally JUDY SCALES-TRENT, NOTES OF A WHITE BLACK WOMAN: 
RACE, COLOR, COMMUNITY 2 (1995); GREGORY HOWARD WILLIAMS, LIFE ON 
THE COLOR LINE: THE TRUE STORY OF A WHITE BOY WHO DISCOVERED HE 
WAS BLACK (1996). 
 3. Scales-Trent, supra note 1, at 1. 
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community about the scientific validity of interpreting an X-ray 
through the lens of race.4 But, he claimed, it is impossible to 
interpret the bone scan without factoring in race because the 
machines that analyze the bone scan can only produce an 
analysis if the race of the person being analyzed is included.5 
The doctor could not explain how the x-ray machine defined 
“race,” replying that the definitions “were created by the 
companies that built the machines.”6 
My friend asked if there was any way she could get more 
helpful advice about the condition of her bones.7 The radiologist 
thought for a moment, then suggested that perhaps my friend 
should have her bone densitometry test performed twice, once 
as “white,” then as “black.”8 The condition of her bones, he told 
her, would lie somewhere between the two results.9 However, 
my friend concluded that “one-half of a fantasy definition of 
‘white’ plus one-half of a fantasy definition of ‘black’ will only 
yield one whole fantasy: it will not provide a sound medical 
diagnosis.” 10 Thus she marked “black” or “African American” 
because that had always been her legal and social identity.11 So 
what did the results really tell her doctor? 
For years my friend taught and wrote about the social 
construction of race and knew that her doctor’s explanation 
about the use of race as a biological term by the radiology 
community was flawed.12 She found it reminiscent of the World 
War II era when the Nazis kept “separate blood banks for 
‘Jewish blood’ and ‘Aryan blood,’ [and] American blood banks 
were separating ‘white blood’ and ‘black blood’.”13 The United 
States has a long and continuing history of “unconscionable 
medical research” involving black Americans.14 
 4. Id. at 2. For further discussion regarding this debate see Anne Fausto-
Sterling, The Bare Bones of Race, 38 SOC. STUD. SCI. 657, 659 (2008). 
 5. Scales-Trent, supra note 1, at 2. 
 6. Id. 
 7. Id. 
 8. Id. 
 9. Id. 
 10. Id. at 3. 
 11. Telephone conversation with Professor Judy Scales-Trent, Professor 
Emerita at The University at Buffalo Law School (Sept. 20, 2010). 
 12. Scales-Trent, supra note 1, at  1–3. 
 13. Id. at 2. 
 14. HARRIET A. WASHINGTON, MEDICAL APARTHEID: THE DARK HISTORY 
OF MEDICAL EXPERIMENTATION ON BLACK AMERICANS FROM COLONIAL TIMES 
 2011] FUNDING RACE AS BIOLOGY 573 
                                                          
In 1950 the United Nations Educational, Scientific and 
Cultural Organization (UNESCO), mindful of race-science’s 
dark and not so distant history,15 drafted a statement on the 
use of race in modern science.16 This statement, developed by 
an esteemed group of anthropologists, psychologists, and 
sociologists, concludes: “[f]or all practical social purposes ‘race’ 
is not so much a biological phenomenon as a [damaging] social 
myth.”17 Today most scientists agree that race and ethnicity 
(ethno-race) classifications are the result of social and political 
conditions, as opposed to biological differences.18 There is, 
however, disagreement about the scientific validity of these 
categories.19 
TO THE PRESENT 2 (2006). 
 15. Raj Bhopal, Is Research into Ethnicity and Health Racist, Unsound, or 
Important Science?, 314 BRIT. MED. J. 1751 (1997); Lundy Braun et al., Racial 
Categories in Medical Practice: How Useful Are They?, 4 PLOS MED. 1423 
(2007); Charis Thompson, Race Science, THEORY, CULTURE & SOC’Y, May 
2006, at 547; WASHINGTON, supra note 14. 
 16. The Race Question in Modern Science: The Race Concept Result of an 
Inquiry, UNITED NATIONS EDUC., SCIENTIFIC AND CULTURAL ORG. (1952), 
available at http://unesdoc.unesco.org/images/0007/000733/073351eo.pdf. 
UNESCO acted in response to “a resolution . . . adopted by the United Nations 
Economic and Social      Council . . . asking UNESCO . . . to consider the 
desirability of initiating and recommending the general adoption of a 
programme of disseminating scientific facts designed to remove what is 
generally known as racial prejudice.” Id. at 6 (punctuation omitted). 
 17. Id. at 101. A half of century later the Human Genome Project seemed 
to confirm the scientific irrelevance of race, finding “high levels of genetic 
similarity within the human species.” Dorothy E. Roberts, Legal Constraints 
on the Use of Race in Biomedical Research: Toward a Social Justice 
Framework, 34 J.L. MED. & ETHICS 526, 526 (2006). For a discussion of the 
Human Genome Project see All About the Human Genome Project, NAT’L 
HUMAN GENOME RESEARCH PROJECT, http://www.genome.gov/10001772 (last 
visited Dec. 7, 2010). As a result, some scholars speculated that genetic 
differences “would replace race as the preeminent means of grouping people 
for scientific purposes.” Roberts, supra, at 526. But genetic differences did not 
replace racial categories, instead, debates about the scientific validity of race 
reemerged in connection with genomic, biomedical and biotechnology research. 
Id. 
 18. See, e.g., Timothy Caulfield et al., Race and Ancestry in Biomedical 
Research: Exploring the Challenges, 1 GENOME MED 8.1, 8.2 (2009); Roberts, 
supra note 17, at 526. 
 19. See generally JENNY REARDON, RACE TO THE FINISH: IDENTITY AND 
GOVERNANCE IN AN AGE OF GENOMICS 4 (2005); S.O.Y. Keita & Rick A. 
Kittles, The Persistence of Racial Thinking and the Myth of Racial Divergence, 
99 AM. ANTHROPOLOGIST 534 (1997); Dorothy Roberts, What’s Wrong with 
Race-Based Medicine?: Genes, Drugs, and Health Disparities, 12 MINN. J.L. 
SCI. & TECH. 1, 2–7 (2011). Because self-identified ethno-race often serves as a 
“poor proxy for underlying genetic relatedness,” many researchers have begun 
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Even though an increasing number of scientists believe 
that too often ethno-race is used as a surrogate for various 
socioeconomic and environmental factors,20 for most of the late 
twentieth century social science and medical researchers 
continued to use ethno-race in a biological context.21  
Nevertheless, there are times when ethno-racial 
designations have value in medical research. As one scholar 
writes, “using race as a social category” to study the impact of 
racism on health and access to medical care is critical to 
eliminating health inequities based on race.22 But, she cautions 
that using race as a biological category can reflect and reinforce 
racial stratification as well as racist notions of inherent human 
difference.23 Several commentators call this phenomenon the 
reification of race, where the social concept of race is 
transformed “into a specific, definite, concrete, and now 
presumably genetic category which can feed back into 
preexisting lay understandings of racial difference.”24 
Congress regulates a great deal of medical research with 
the promise of federal monies. The relevance of ethno-race in 
medical research has been heightened by two decades of federal 
legislation, most notably the U.S. National Institutes of Health 
Revitalization Act of 1993 (Revitalization Act), which contains 
initiatives on minority health.25 The Revitalization Act 
requires that, among other things, women and “minority 
using DNA estimates of ancestry (ancestral DNA) in genetic-association 
research. Caulfield et al., supra note 18, at 8.2. The major genetic variations, 
however, correspond to the major continents, giving rise to the same racial 
distinctions the use of ancestry seeks to avoid. Id. at 8.2. 
 20. Otis W. Brawley & Harold P. Freeman, Race and Outcomes: Is This 
the End of the Beginning for Minority Health Research?, 91 J. NAT’L CANCER 
INST. 1908, 1908 (1999). 
 21. See Braun, supra note 15, at 1424. 
 22. Roberts, supra note 17, at 527. 
 23. Id. 
 24. OSAGIE K. OBASOGIE, CENTER FOR GENETICS & SOC’Y, PLAYING THE 
GENE CARD? A REPORT ON RACE AND HUMAN BIOTECHNOLOGY 5 (2009), 
available at http://geneticsandsociety.org/downloads/complete_PTGC.pdf. 
Jonathan Kahn argues that the approval of BiDil signals that “powerful 
federal agencies have acknowledged the legitimacy of using race as a marker 
for biological difference.” Jonathan Kahn, How a Drug Becomes “Ethnic”: Law, 
Commerce, and the Production of Racial Categories in Medicine, 4 YALE J. 
HEALTH POL’Y & ETHICS 1, 33 (2004). Anthropologist Alan Goodman 
characterizes this type of research as a “‘comeback’ in ‘racialized notions of 
biology.’” Id. 
 25. See 42 U.S.C. § 201 (1993); see also Roberts, supra note 17, at 527. 
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groups” be included in all intramural and extramural National 
Institutes of Health (NIH) funded biomedical and behavioral 
research.26 Since most biomedical research is funding driven, 
minority health initiatives may, by promoting greater racial 
diversity among clinical subjects, generate a medical research 
market that unintentionally promotes the misuse of ethno-
race.27 
Some commentators express concern about the resulting 
re-emergence of race in biomedical studies, but most concede 
that legal challenges to the current medical research practices 
may not be the most effective means of quickly minimizing or 
remedying the problem.28 Further, litigation may actually 
discourage needed and valid race related studies.29 Courts, 
searching for ethno-racial medical biases, may become 
overzealous and act in ways that actually thwart positive race-
related medical research, such as inquiries into access to care 
and equal treatment.30 In addition, federally funded biomedical 
research that uses race inappropriately is socially harmful 
because, as I will discuss throughout this article, the practice 
tends to perpetuate the disputed notion that race is biological, 
and it evokes the historical baggage associated with race-
science. Thus, due to the probable ineffectiveness of legal 
challenges, some government regulation or oversight is 
warranted where public funds are involved. 
Only a handful of legal scholars have addressed the 
dangers inherent in the uncritical use of ethno-race in medical 
studies and the debates within the biomedical research 
community about the use of ethno-race in research.31 None, I 
 26. Karen H. Rothenberg, Gender Matters: Implications for Clinical 
Research and Women’s Health Care, 32 HOUS. L. REV. 1201, 1231 (1996). 
 27. See Roberts, supra note 17, at 529. 
 28. For a discussion of this point see Osagie K. Obasogie, Beyond Best 
Practices: Strict Scrutiny as a Regulatory Model for Race-Specific Medicines, 
36 J.L. MED. & ETHICS 491, 494–95 (2008) (discussing the strengths and 
weaknesses of applying a constitutional law based “strict scrutiny” approach 
to the use of race-specific labels in the pharmaceutical field). 
 29. Erik Lillquist & Charles A. Sullivan, The Law and Genetics of Racial 
Profiling in Medicine, 39 HARV. C.R.-C.L. L. REV. 391, 466–68 (2004) (noting 
the potential loss of certain beneficial race-based medical research). 
 30. Id. at 466. 
 31. See Kahn, supra note 24 (arguing for tighter Food and Drug 
Administration (FDA) regulation of race specific drugs); Lillquist & Sullivan, 
supra note 29 (exploring the constitutionality of using race in scientific 
research); Obasogie, supra note 28 (focusing on the role of the FDA in 
determining whether to approve race specific medicine); Roberts, supra note 
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contend, provide a comprehensive overview of the issue nor 
propose an effective remedy. While there is a general consensus 
that race and other social classifications influence health, 
“there is little agreement about why or how [ethno-] race 
matters, how best to study its effects and how to translate and 
communicate research results from racially stratified 
studies.”32 
Legal scholar Dorothy Roberts posits that “[f]ederal 
funding agencies’ control over the funding for biomedical 
research is a powerful basis for restricting the use of race” in 
medical studies.33 She also offers a few general suggestions for 
how funding restrictions might operate.34 In this article I build 
on Roberts’ initial suggestions by offering more specific 
recommendations for federal funding restrictions on biomedical 
research that uses ethno-racial categories. 
This article proceeds from the assumption that there are 
few clear instances, other than perhaps access to health care or 
measuring equality in medical treatment, where the use of 
ethno-race in medical research is appropriate. Even in those 
limited situations the justification for using ethno-race, how 
the ethno-racial categories are defined, and the method for 
assigning ethno-race warrant close scrutiny and oversight, 
especially when these studies are funded with federal money. 
In the next section, this article explains the scientific basis for 
that assertion. First, it explores the debates within the medical 
community about the connection between race and biology in 
biomedicine. Then it  examines literature on race-related stress 
to determine whether this might be an instance where ethno-
racial labels help explain health outcomes, and argues that 
17 (proposing a “social justice framework” designed to encourage the 
appropriate use of race in medical research); Michael D. Ruel, Using Race in 
Clinical Research to Develop Tailored Medications Is the FDA Encouraging 
Discrimination or Eliminating Traditional Disparities in Health Care for 
African Americans?, 27 J. LEGAL MED. 225 (2006) (arguing that while using 
race in medical trials is acceptable, the government needs to develop rules on 
this based on scientific evidence to make sure discrimination does not occur). 
 32. Caulfield et al., supra note 18, at 8.2 (concluding that “[r]esearch that 
simultaneously assesses both genetic and environmental contributions to 
disease risk, drug response and other health-related variation, and that 
deliberately puts such findings in the context of self-identified race, is urgently 
needed,” or else race will continue to be used, problematically, in biomedical 
research). 
 33. Roberts, supra note 17, at 529. 
 34. Id. at 530–33. 
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guidelines or regulation are needed. 
The third section of this article examines two sets of 
guidelines on the use of ethno-race in biomedical research: 
guidelines adopted by high impact medical journals, and 
federal guidelines on the use of ethno-race in federally funded 
biomedical research. Finding these measures inadequate, this 
article argues that the only way to quickly change research 
behavior in this area is through greater regulation and 
oversight of federal medical research grants. More stringent 
government regulation and oversight of federally funded 
biomedical research grants that use ethno-race may trigger 
changes in the medical culture faster than litigation. 
In the fourth section this article proposes a regulatory 
scheme that offers a standard to measure the appropriateness 
of ethno-race in applications for federally funded biomedical 
research that will cause both researchers and grant reviewers 
to give more thought to how and why ethno-race is used in 
research protocols. This article concedes that this proposal is 
only a first step, and acknowledges that meaningful progress 
also requires strong and effective measures designed to change 
how biology is taught in undergraduate, graduate, and 
professional schools. But without a change in the medical 
culture, another generation of researchers and health care 
providers will be trained to think about ethno-racial differences 
inappropriately. 
Before effective remedies for the problem described can be 
discussed, it is important to clarify both the meaning and use of 
the term “race” in scientific discussions. The next section of this 
paper looks at debates within the scientific community about 
the meaning of ethno-racial labels. 
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II. “IF RACE IS THE ANSWER, WHAT IS THE 
QUESTION?”35 DEBATES ON THE USE OF RACE IN 
RESEARCH 
A. LINKS BETWEEN RACE AND BIOLOGY 
1. Contemporary Debates 
In the late nineteenth century “scientists [named and] 
ranked races on their biological and social worth.”36 Much of 
the resulting research from this era is “racist, unethical, and 
ineffective.”37 Even more troubling, race-science was used to 
justify slavery, anti-immigration policies, and imperialism.38 
Although race-science was abandoned by the mid-twentieth 
century, a few researchers in the 1990s expressed concerns that 
ethno-race was still being misused in contemporary biomedical 
research.39 This section looks at the debates within research 
communities about the use of racial categories in biomedical 
research. 
Most contemporary scientists concede that nineteenth 
century stereotypes of race and racial variations probably 
reflect the superficial understanding of the relationship 
between ethno-race and biological difference or lack of 
 35. Taken from the title of an article about the misuse of “race” as 
explaining persistent health outcome disparities among racial and ethnic 
groups in the United States. Nancy Krieger, If “Race” is the Answer, What is 
the Question?—On “Race,” Racism, and Health: A Social Epidemiologist’s 
Perspective, IS RACE REAL?, SOC. SCI. RES. COUNCIL (June 7, 2006), 
http://raceandgenomics.ssrc.org/Krieger/. 
 36. Bhopal, supra note 15, at 1751. 
 37. Id. 
 38. Id. 
 39. See Trevor A. Sheldon & Hilda Parker, Race and Ethnicity in Health 
Research, 14 J. PUB. HEALTH MED. 104, 104 (1992). The authors write that 
“[h]ealth research appears to be reflecting the process of ‘racialization’ . . . 
whereby the idea of race or ethnicity is increasingly being introduced to help 
define or give meaning to the population [being studied]” and argue for more 
thought and care in the use of race and ethnicity as health research variables. 
Their article was part of a debate within the United Kingdom about the use 
and misuse of race and ethnicity. See, e.g., R.S. Bhopal et al., Inappropriate 
Use of the Term ‘Asian’: An Obstacle to Ethnicity and Health Research, 13 J. 
PUB. HEALTH MED. 244 (1991); Jenny L. Donovan, Ethnicity and Health: A 
Research Review, 19 SOC. SCI. MED. 663, 668 (1984) (concluding that studying 
particular diseases or illnesses affecting ethnic groups tends to place blame on 
subalterns rather than attributing these health problems to economic and 
social structures). 
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difference held by scientists in that era.40 The debate 
continues, however, over whether race has any legitimacy as a 
scientific concept, and more fundamentally, whether and how 
to study human biological diversity. Biologist Marcus Feldman 
and his co-authors write: “[t]he issue of whether race is a 
biologically useful or even meaningful concept when applied to 
humans in a medical context is controversial.”41 But the 
authors claim that there really is “no contradiction” between 
the bodies of evidence on each side of the debate. This is 
because the issue conflates two different questions: whether 
distinguishable DNA sequences related to “major geographical 
origin” exist and whether “most genetic diversity occurs within 
groups.”42 The answer to both questions, according to the 
authors, is yes.43 Therefore, those who argue that race is 
relevant present evidence linking race to geographic origin, and 
those who argue that race is irrelevant present evidence of 
genetic diversity within racial groups. 
This debate does not contest the use of socially constructed 
ethno-racial categories to measure differences in access to 
health care, delivery of health care, and equal medical 
treatment. Studies such as these measure social attitudes of 
health care providers. Therefore, they are distinguishable from 
studies that use ethno-race to explain biological differences in 
disease or medical outcomes unrelated to social disparities in 
health care.44 Nevertheless, as my friend’s bone density test 
experience illustrates, the undifferentiated connection between 
race and biology persists in America. 
 40. See, e.g., Bhopal supra note 15, at 1752; Braun, supra note 15, at 
1724; Thompson, supra note 15, at 547. 
 41. Marcus W. Feldman et al., A Genetic Melting-Pot, 424 NATURE 374, 
374 (2003). The authors explain: 
Race as a biological concept has had a variety of meanings. In the 
taxonomic literature, a race is any distinguishable type within a 
species . . . . In 1937, Theodosius Dobzhansky introduced the idea of 
geographical races—populations of species that differ in the 
frequencies of one or more genetic variants . . . . The classical 
definition of race . . . is based on phenotypes such as skin colour, 
facial features and hair . . . . An underlying assumption is that all of 
these defining features . . . are characteristic of the genome in 
general. 
Id. 
 42. Id. 
 43. Id. 
 44. See supra notes 1–13 and accompanying text. 
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2. SICKLE CELL DISEASE AND RACE 
Discussing the connection between race and genetics, 
Feldman and his co-authors argue that ancestral geographical 
origin can be useful in diagnosis and treatment, but that a 
person’s racial classification, whether self-identified or 
assigned, “is both too broad and too narrow a definition of 
ancestry to be biologically useful.”45 They specifically cite 
sickle-cell disease, widely thought by Americans to be a trait 
connected to African ancestry, but which in reality is 
“characteristic of ancient ancestry in a geographic region where 
malaria was endemic.”46 Since individuals with the sickle cell 
trait do not get malaria, researchers now believe that the trait 
is a genetic mutation that developed as a protective measure in 
areas around the world where malaria is common.47 
Malaria most often found in Africa, once was common 
around the Mediterranean as well.48 Thus, the trait also is 
found in “Portuguese, Spaniards, French Corsicans, 
Sardinians, Sicilians, mainland Italians, Greeks, Turks and 
Cypriots.”49 Today, sickle-cell disease is most common in 
Middle Eastern countries like Lebanon, Israel, Saudi Arabia, 
Kuwait and Yemen and Near Eastern countries like India and 
 45. Feldman et al., supra note 41, at 374. 
 46. Id.; see also Anthony C. Allison, Two Lessons From the Interface of 
Genetics and Medicine, 166 GENETICS SOC’Y AM. 1591, 1592 (2004) (finding, 
when testing his hypothesis that sickle cell was related to malaria, that the 
“distribution, involving diverse populations, supported the belief that an 
environmental factor, malaria transmission, was the principle determinant of 
high sickle-cell frequencies”); Donovan, supra note 39, at 665 (“Sickle-cell 
anemia first occurred in Britain when immigrants arrived from Africa and the 
Caribbean where the disease had developed to give partial immunity to 
endemic malaria.”). 
 47. See, e.g., Allison, supra note 46, at 1592–93; Blood Diseases, U. MD. 
MED. CENTER, http://www.umm.edu/blood/sickle.htm (last updated Jan. 30, 
2008). 
 48. Blood Diseases, supra note 47. 
 49. McKinley Health Center, Sickle Cell Disease, U. OF ILL. AT URBANA-
CHAMPAIGN (Mar. 7, 2007), 
http://www.mckinley.illinois.edu/handouts/sickle_cell_disease.html. According 
to the National Heart Lung and Blood Institute, sickle cell anemia is “most 
common in people whose families come from Africa, South or Central America 
(especially Panama), Caribbean islands, Mediterranean countries (such as 
Turkey, Greece, and Italy), India, and Saudi Arabia.” See also Who Is at Risk 
for Sickle Cell Anemia?, NAT’L HEART LUNG AND BLOOD INST., 
http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_WhoIsAtRisk.html (last 
visited Dec. 7, 2010). 
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Sri Lanka.50 
The tendency in the United States to link sickle-cell 
disease to black Americans stems from the fact that black 
Americans are more likely than any other ethno-racial group in 
the country to have the sickle-cell trait.51 A closer examination 
of the evidence indicates, however, that geography, rather than 
race, factors into the trait’s prevalence.52 Most black Americans 
are descendants of enslaved Africans from West and Central 
Africa where the disease is most common.53 It follows, 
therefore, that in the United States, African ancestry is a factor 
in the prevalence of sickle-cell among black Americans. 
Although most states routinely test all newborns for the trait,54 
public health officials may continue to link sickle-cell to race 
and target only black Americans for outreach.55 This results 
from an incorrect assumption that the prevalence of sickle cell 
among black Americans is due to a connection between biology 
and race. 56 
As Feldman and his co-authors caution, other variables 
like migration and mating may result in new populations, thus, 
“[a] person classified as ‘black’ or ‘Hispanic’ by social 
convention could have any mixture of ancestries, as defined by 
 50. Who Is at Risk for Sickle Cell Anemia?, supra note 49. 
 51. Eight percent of African Americans have the sickle cell trait. DIV. OF 
BLOOD DISEASES AND RESOURCES, NAT’L INST. OF HEALTH, THE MANAGEMENT 
OF SICKLE CELL DISEASE 15 (4th ed. 2002), available at 
http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf; Learning About 
Sickle Cell Disease, NAT’L HUMAN GENOME RESEARCH INSTITUTE, available at 
http://www.genome.gov/page.cfm?pageID=10001219 (last visited Dec. 16, 
2010) (“In the United States, sickle cell disease is most prevalent among 
African Americans. About one in 12 African Americans and about one in 100 
Hispanic Americans carry the sickle cell trait . . . .”). 
 52. See generally Allison, supra note 46. 
 53. Who Is at Risk for Sickle Cell Anemia?, supra note 49. According to the 
University of Maryland Medical Center, “[s]ickle cell disease primarily affects 
those of African descent and Hispanics of Caribbean ancestry, but the trait 
has also been found in those with Middle Eastern, Indian, Latin American, 
Native American, and Mediterranean heritage.” U. MD. MED. CTR., supra note 
47. 
 54. U. MD. MED. CTR., supra note 47. 
 55. See Braun et al., supra note 15, at 1425–26 (arguing that “[i]n the case 
of sickle cell disease, it would be best to work from symptoms rather than 
racial assumptions, and to enquire about geographic ancestry since sickle cell 
is more prevalent in populations from the Mediterranean region, sub-Saharan 
Africa, and the Indian subcontinent”). 
 56. Id. at 1426. 
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continent of origin.”57 Physicians might fail to test individuals 
for sickle cell disease because they are not classified as black. If 
the disease remains undiagnosed and untreated, severe 
medical consequences, or even death, may result. Thus, it may 
be more important to know a patient’s family medical history 
than race, since a person who identifies as black or white may 
have grandparents or great grandparents whose ancestral 
geographical origins include areas where the trait or disease is 
common.58 
3. BONE DENSITY AND RACE 
Similarly, some researchers continue to argue that there is 
a correlation between race and biology in bone density. 
According to the first sentence of an article in a 2008 issue of 
the Journal of Nutrition: “Diet and race are important 
predictors of areal bone mineral density (aBMD) and fracture 
risk.”59 The introductory sentence reads like a general fact; it is 
not footnoted.60 Under the subheading, Racial differences in 
bone density, the authors write: 
African American men and women have higher aBMD than other 
racial groups, including American white, Asian, Hispanic, and Native 
Americans. Such differences are attenuated but still generally persist 
when aBMD data are adjusted for weight, bone size, and other 
 57. Feldman et al., supra note 41, at 374 (arguing that social race 
“provides information about the social circumstances and lifestyle of 
patients”). However, even this description ignores the heterogeneity and class 
differences within populations raced as black in America. 
 58. “A ‘black’ person walking into a Boston, Massachusetts clinic could 
easily be the child of a recent immigrant from Ethiopia or Brazil who has a 
genetic makeup as well as cultural and environmental exposures that differ 
significantly from the descendents of 19th century US [sic] slaves from the 
western coast of Africa.” Braun et al., supra note 15, at 1426. Another 
researcher wrote: “In the case of sickle cell disease, it would be best to work 
from symptoms rather than racial assumptions, and to enquire about 
geographic ancestry.” Id. Thus Feldman et al. conclude that a better approach 
is to identify “all contributions to a patient’s ancestry” when “diagnosing and 
treating disease with genetic influences.” Feldman et al., supra note 41, at 
374. 
 59. Marcella D. Walker et al., Race and Diet Interactions in the 
Acquisition, Maintenance, and Loss of Bone, 138 J. NUTRITION 1256S, 1256S 
(2008). 
 60. There is, however, reason to doubt these “important predictors.” See 
Marc C. Hochberg, Racial Differences in Bone Strength, 118 TRANSACTIONS 
AM. CLIN. & CLIMATOLOGICAL ASS’N 305, 308–10 (2007) (discussing several 
studies that support the claim that whites have lower bone mineral density 
than blacks). 
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covariates, such as physical activity, calcium intake, smoking, and 
alcohol use.61 
The authors base these statements on earlier studies of 
fracture risk and bone density among various ethnic groups.62 
These earlier studies are the basis for the different 
measurement standards for determining bone density that 
were applied to my friend. 
The same year as the aforementioned study, biologist and 
feminist scholar Anne Fausto-Sterling asked whether accepted 
studies on bone density that report notable differences based on 
race really reflect racial differences and if so, what this means 
“biologically and socially.”63 Fausto-Sterling looked at a sample 
of published research to determine how researchers defined 
race in studies examining claims about the relationship 
between race and bones. She notes that many early papers 
discussing bone density cite to Mildred Trotter’s work in the 
1960s and 1970s,64 but that new technology prompted a shift 
away from Trotter’s methods to large-scale studies.65 The 
change in methodology, however, was not accompanied by a 
shift in thought about the use of race as a factor. Fausto-
Sterling takes issue with these modern studies, arguing they 
reveal “profound inconsistencies in the definitions and modes of 
ascertainment of racial categories, a lack of theory about why 
race might be an important study variable, and no clear 
rationale about how race might exert effects on bone biology.”66 
Yet papers addressing bone density into the early twenty-
first century still began with the presumption that race-based 
differences in bone density are “incontrovertibly established.”67 
 61. Walker et al., supra note 59, at 1256S–57S. 
 62. Id. 
 63. Fausto-Sterling, supra note 4, at 659. Fausto-Sterling’s question 
applies to biomedical, biotechnological, and genomic research generally, but 
this article only focuses on biomedical or medical research. 
 64. Trotter was a well-known anatomist and anthropologist whose 
professional career spanned from 1922 until 1984. “Her research led to 
discoveries about the structure and distribution of hair, and the growth, racial 
and sexual differences, and aging of the human skeleton. Additionally, her 
work in skeletal biology led to the creation of formulas to estimate stature 
based on the lengths of long leg bones.” Missouri Women in the Health 
Sciences: Mildred Trotter, WASH. U. ST. LOUIS SCH. OF MEDICINE, 
http://beckerexhibits.wustl.edu/mowihsp/bios/trotter.htm (last visited Dec. 7, 
2010). 
 65. Fausto-Sterling, supra note 4, at 661. 
 66. Id. at 662. 
 67. Id. 
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As such, Fausto-Sterling argues based on her research, these 
studies are suspect because the scientists used race 
uncritically.68 She is not alone in her criticism, which applies 
equally to other medical research studies. 
B. DEBUNKING THE LINK BETWEEN RACE AND BIOLOGY 
In the late 1990s, American social scientists spoke out 
strongly against connecting race with biology. After studying 
the issue, the Executive Committee of the American 
Anthropological Association (AAA) concluded: “present-day 
inequalities between so-called ‘racial’ groups are not 
consequences of their biological inheritance but products of 
historical and contemporary social, economic, educational, and 
political circumstances.”69 The AAA’s statement reflects the 
concerns expressed two years earlier by British social 
researchers attempting to fashion a framework for the 
 68. She writes that “the social [notion of racial distinction] produces the 
biological in a system of constant feedback between body and social 
experience.” Id. at 658 (emphasis in original). The accepted scientific 
assumption for bone disease in adults is that white and Asian women are at 
highest risk, followed by Hispanic women, then by white and Asian men, then 
Hispanic men, then black men. Black women have rates similar to white men. 
Id. Further, as my colleague Amanda Pustilnik commented to me, even if 
these findings were real, their significance is open to question. If what matters 
is fracture risk, and fracture risk results from current bone density—not 
percentage of bone loss from baseline—then a starting point would seem 
irrelevant. But if a starting point mattered, then it seems that the doctor 
would want to compare that patient’s current results to her own, individual 
scan taken at Time 1. There must be all kinds of starting point bone density 
differences, depending on childhood nutrition, individual genetics, childhood 
sports, etc. So not only is the “racial” dimension of this claim questionable, the 
whole starting point position seems to be a pure nonsense dimension. 
 69. Statement on “Race”, AM. ANTHROPOLOGICAL ASS’N (May 17, 1998), 
http://www.aaanet.org/stmts/racepp.htm. A few years earlier the AAA adopted 
a resolution that read in part: “differentiating species into biologically defined 
‘races’ has proven meaningless and unscientific as a way of explaining 
variation.” Statement on “Race” and Intelligence, AM. ANTHROPOLOGICAL 
ASS’N (Dec. 1994), http://www.aaanet.org/stmts/race.htm. Almost a decade 
later, social scientist Troy Duster repeated this concern about the “current 
understandings of the relationship between race and disease . . . [and the 
increasing reliance on] genetically oriented biomedical scientists . . . to define 
and identify causes for a wide-ranging set of problems—from alcoholism to 
gender and racial health disparities.” Fausto-Sterling, supra note 4, at 657 
(citing the 2005 inaugural address of Troy Duster, Comparative Perspectives 
and Competing Explanations: Taking on the Newly Configured Reductionist 
Challenge to Sociology, AM. SOC. REV 1 (2006)). 
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“classification of ethnic or cultural groups.”70 They argued that 
when medical researchers use ethno-racial categories, under 
the belief that ethno-race explains the differences in disease 
patterns, the onus should be on the researchers to clearly 
establish the biological correlation.71 Unlike the British model, 
the later AAA statement contains no qualifiers; no 
circumstances when the use of ethno-racial classifications is 
warranted. This absolutist approach is a sticking point with 
some researchers who believe that there are instances where 
ethno-racial categories can function as both an ascriptive factor 
(“to identify the causal mechanisms involved and to select 
clinical interventions”)72 and as a descriptive factor (“to 
document progress in the health status of populations”).73  
Other researchers argue that ethno-race is only relevant in 
biomedical research as a descriptor.  But even in this instance 
researchers have yet to agree on how to define ethno-racial 
categories. 
Two articles that appeared in the September 2007 issue of 
PLoS Medicine, a peer-reviewed journal published by the 
Public Library of Science, illustrate the ongoing debate in the 
medical research community about the use of ethno-race. The 
first, written by Lundy Braun (with Fausto-Sterling and other 
co-authors), begins by drawing the distinction between the 
importance of the descriptive use of racial and ethnic 
categories, as negative health outcomes differ among racial and 
ethnic groups, and the widespread ascriptive use of U.S. census 
ethno-racial categories in biomedical research.74 The misuse of 
ethno-racial categories in the latter instance, Braun et al. 
argue, is reinforced by the National Institutes of Health’s (NIH) 
funding regulations designed to ensure greater inclusion of 
 70. Kwame McKenzie, Describing Race, Ethnicity, and Culture in Medical 
Research, 312 BRIT. MED. J. 1054, 1054 (1996) (also noting that the U.K. 
adopted categories used by the Office of Population Censuses and Surveys for 
use in the 1991 census). See also Mike Pringle & Ian Rothera, Practicality of 
Recording Patient Ethnicity in General Practice: Descriptive Intervention 
Study and Attitude Survey, 312 BRIT. MED. J. 1080, 1082 (1996) (ethnicity 
should be self-defined and is of questionable value in general practice). 
 71. See McKenzie, supra note 70. 
 72. George T.H. Ellison et al., Racial Categories in Medicine: A Failure of 
Evidence-Based Practice?, 4 PLOS MED. 1434, 1434 (2007). 
 73. Braun et al., supra note 15, at 1427. See also Ellison et al., supra note 
72, at 1424 (defining the descriptive use as “to identify differences in health 
and health care that warrant further investigation and intervention”). 
 74. Braun et al., supra note 15, at 1423. 
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racial/ethnic minorities in clinical research.75 These regulations 
use the racial and ethnic categories as defined by the U.S. 
Office of Management and Budget (OMB)’s Directive No. 1576 
to measure inclusion rates. The result is “poorly defined racial 
categories [that become] reified in biomedical research 
practices.”77 
Consider, for example, the classification problem that 
might arise if a clinical protocol calls for the physician to 
identify the race of a man who immigrated to the United States 
at a young age and self-identifies as Cape Verdean.78 “The 
large Cape Verdean population in New England resists any 
simple categorization. The inhabitants are the descendents of 
Portuguese colonists, former slaves, explorers, and sailors of 
 75. Id. at 1424 (noting that the Institute of Medicine’s (IOM) definition of 
race, is an example of how “granting agencies’ regulations do little to clarify 
the extent to which racial and ethnic categories are intended to capture 
biological, cultural, or social dimensions of human diversity”). 
 76. NIH Policy and Guidelines on the Inclusion of Women and Minorities 
as Subjects in Clinical Research, U.S. DEP’T HEALTH & HUM. SERVS. (Oct. 
2001), 
http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_200
1.htm. For a discussion of this point, see Braun et al., supra note 15, at 1424. 
The American Anthropological Association describes OMB Directive 15 as 
follows: 
The Statistical Policy Division, Office of Information and Regulatory 
Affairs, of the Office of Management and Budget (OMB) determines 
federal standards for the reporting of “racial” and “ethnic” statistics. 
In this capacity, OMB promulgated Directive 15: Race and Ethnic 
Standards for Federal Statistics and Administrative Reporting in 
May, 1977, to standardize the collection of racial and ethnic 
information among federal agencies and to include data on persons of 
Hispanic origins, as required by Congress. Directive 15 is used in the 
collection of information on “racial” and “ethnic” populations not only 
by federal agencies, but also, to be consistent with national 
information, by researchers, business, and industry as well. 
Directive 15 described four races (i.e., American Indian or 
Alaskan Native, Asian or Pacific Islander, Black, and White) and two 
ethnic backgrounds (of Hispanic origin and not of Hispanic origin). 
The Directive’s categories allowed collection of more detailed 
information as long as it could be aggregated to the specified 
categories. 
American Anthropological Association Response to OMB Directive 15: Race 
and Ethnic Standards for Federal Statistics and Administrative Reporting, 
AM. ANTHROPOLOGICAL ASS’N (Sept. 1997), 
http://www.aaanet.org/gvt/ombdraft.htm [hereinafter Response to OMB 
Directive 15]. 
 77. Braun et al., supra note 15, at 1423–24. 
 78. Id. at 1424. 
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various nationalities.”79 Given this reality, is the subject black? 
Is the subject “now African American or should [the physician] 
consider [the subject’s] health needs from the perspective of his 
immigrant status? The data on response to therapy seem to 
suggest that hypertension in blacks is somehow special, 
implying a separate genetic factor for blacks.”80 
Given the historical misuse of ethno-racial categories in 
ways that perpetuate notions about racial inferiority, Braun et 
al. ask whether ethno-race is a useful factor to consider in 
determining medical care.81 Their concern is that physicians, 
relying on race-based biomedical research, will make diagnoses 
or risk assessments and treatment decisions based on a 
person’s race rather than using a procedure that considers 
factors like environment, family history, stress, and other 
socioeconomic contributors to health disparities.82 Braun et al. 
argue that because racial categories are deceptively simple they 
conceal diverse internal populations. For example, a person 
with black, white, and Native American ancestors may self-
identify as black, as would a recent immigrant from Ethiopia. 
Rather than work from racial assumptions, some grounded in 
geographic ancestry, Braun et al., like Feldman and his co-
authors, argue that researchers should focus on individual 
symptoms.83 Otherwise, “[o]nce race is presumed . . . [c]linical 
clues can become invisible.”84 
To counter this troubling trend, Braun et al. recommend 
educating medical researchers and practitioners about cultural 
competency, historical misuse of racial categories, current 
debates about the validity of ethno-race in medicine, limits of 
racial categorization in the medical context, population race 
 79. Id. 
 80. Id. (explaining that “African Americans suffer at rates 3.5 times those 
of Nigerians living in Africa, although African Americans experience only 0.75 
the rates of Germans in Germany. Which category matters more for [a] 
patient, country of origin or social status in the adopted nation?”) (internal 
citations omitted). 
 81. Id. at 1424–25. 
 82. Id. 
 83. Id. at 1426. Braun et al. also discuss the idea of cultural competency, 
espoused in some quarters, which encourages clinicians to “familiarize 
themselves with the history of the particular communities they serve.” 
Conceding that the approach may have some benefits (“[it] brings greater 
attention to the attitudes and behaviors that patients may bring to the clinical 
encounter”), they also believe it brings the danger that the clinician may see 
patients as “types” rather than individuals. Id. 
 84. Id. at 1425–26. 
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versus individual race, and geographical genetic variation.85 
While they acknowledge the need for “an international 
consensus” on the use of ethno-racial categories in science, they 
argue for more immediate action by the NIH in reevaluating its 
policies on racial categorization and by medical schools in 
improving their instruction on race in medicine.86 
Medical anthropologist George T.H. Ellison and his co-
authors recognize the challenges to instituting more precise 
attributive factors as well as the need to distinguish between 
the descriptive use of ethno-racial categories, and the ascriptive 
use of such categories.87 Ellison and his co-authors, however,  
find Braun and her co-authors’ proposals problematic. First, 
they point to a “lack of consensus about what race and ethnicity 
mean and how these [categories] should be operationalised.”88 
Second, while researchers know that ethno-racial categories are 
inaccurate, Ellison et al. adopt a “pragmatic” approach to NIH 
requirements designed to insure greater representation of 
ethno-racial groups in research studies.89 Ellison et al., like 
Braun et al., worry that the crude ethno-racial categories that 
NIH uses to monitor inclusion of racial and ethnic minorities in 
clinical trials and to describe differences in health care and 
health outcomes actually may be harmful. They warn that NIH 
policies that use OMB-like ethno-racial categories for these 
purposes may undermine efforts to ascertain “more precise 
 85. Id. at 1426–27. 
 86. Id. at 1427. Braun et al. ends by restating the distinction drawn by 
anthropologist Michael Montoya between using ethno-race descriptively and 
ascriptively. Id. 
 87. Ellison et al., supra note 72, at 1435. 
 88. Id. at 1434. Ellison et al. concede this lack of consensus means that 
“researchers and practitioners may conflate the utility of racial and ethnic 
categories for sampling diverse study populations with their ability to identify 
and address aetiological variation therein.” Id. (internal citations omitted). 
Ellison et al. argue that Braun’s proposal “would require unprecedented 
agreement amongst a comprehensive international consortium of funders and 
providers” about the use of ethno-racial categories. Id. at 1436. 
 89. Id. Ellison et al. concede that “[t]he use of crude socio-political 
categories of race and ethnicity to describe variation in health risks and health 
needs, and to attribute these differences to innate genotypic and socio-cultural 
factors, has a long and discredited history.” Id. at 1435. In an effort to avoid 
stigmatizing particular racial or ethnic groups, some researchers “adopt the 
more socially acceptable term ‘ethnicity’ in preference to ‘race,’” while other 
researchers adopt “crude socio-political classifications” such as the OMB 
categories. Id. 
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attributive evidence.”90 Ellison and his co-authors propose that 
ethno-racial categories be used only as “descriptive variables in 
different scientific, clinical, and social contexts.”91 They argue 
that other genetic, cultural, or structural markers need to be 
identified and developed to provide a more precise causal 
connection of the disparities in health and health care.92 
 
C. STRESS AND BLACK AMERICANS: DOES SOCIAL RACE HAVE A 
BIOLOGICAL COMPONENT? 
The foregoing discussion does not squarely address another 
question, whether there is validity in doing research on 
different race-based outcomes that flow from social and 
environmental factors. Arguably, there could be a biological yet 
socially created reality to race differences in health. This 
section explores what might be required to make such research 
useful. 
Medical experts agree that stress can affect the onset, 
progression, and severity of illness, and that racism and race-
related stress have an impact on health.93 Stress literature 
 90. Id. While racial and ethnic categories are helpful for descriptive 
purposes, Ellison et al. argue that “researchers and clinicians do need to be 
encouraged to use more specific attributive markers of genotype, culture, and 
structural disadvantage wherever appropriate.” They argue that the use of 
racial and ethnic categories in describing differences in health risks and 
outcomes might result in the same crude categories being misattributed as the 
cause of health differences. Id. 
 91. Id. 
 92. Id. 
 93. David R. Williams & Selina A. Mohammed, Discrimination and Racial 
Disparities in Health: Evidence and Needed Research, 32 J. BEHAV. MED. 20, 
27 (2009) (explaining how, according to stress literature, stress affects the 
onset, progression, and severity of illness, and describing several health 
conditions that may be affected by stress, including five physiological 
categories where stress has been shown to affect symptoms (neuroendocrine 
system, cardiovascular system, gastrointestinal system, pain sensitivity and 
chronic pain, and immune function)). Williams and Mohammed also encourage 
future research that “focus[es] its attention on those outcomes where prior 
research has documented that stress in general is linked to health.” Id. at 38. 
See also Elizabeth Brondolo et al., Race, Racism and Health: Disparities, 
Mechanisms, and Interventions, 32 J. BEHAV. MED. 1, 3 (2009) (noting that 
exposure to racism, in any form, may initiate a series of “acute and enduring 
changes in cognition, affect, behavior, and psychophysiological responses”); 
Yin Paradies, A Systematic Review of Empirical Research on Self-Reported 
Racism and Health, 35 INT’L J. EPIDEMIOLOGY 888, 893 (2006) (reporting that 
a group of twenty-six studies revealed a significant association between self-
reported racism and 44% of certain health outcomes, including blood pressure, 
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suggests that acute and chronic experiences with racism have 
different effects on illness and disease.94 The strongest 
association has been found between racism and negative 
mental health outcomes.95 Some studies have also found a 
relationship between racism and certain physical health risks, 
conditions, or behaviors.96 
Overall, the associations between racism and health vary 
among different ethno-racial groups, with black Americans 
experiencing the strongest associations and white Americans 
experiencing the weakest associations, even when 
socioeconomic factors are taken into account.97 It is important 
to note, however, that whites generally experience less racism 
than non-whites, which may explain the different race-related 
birth weight, BMI/obesity, and mortality; 36% of all negative health outcomes 
were significantly associated with racism). 
 94. Williams & Mohammed, supra note 93, at 33. 
 95. Id. at 22; Paradies, supra note 93, at 892. 
 96. See Paradies, supra note 93, at 893 (finding that 44% of negative 
physical health outcomes were “significantly associated with self-reported 
racism” based on measured physical health outcomes including blood pressure, 
birth weight, BMI/obesity, and mortality); Shawn O. Utsey et al., Effect of 
Ethnic Group Membership on Ethnic Identity, Race-Related Stress and Quality 
of Life, 8 CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOL. 366, 368 (2002) 
[hereinafter Effect of Ethnic Group Membership] (discussing the effects of race-
related stress response on the immune, neuroendocrine, and cardiovascular 
systems); Shawn O. Utsey et al., Race-Related Stress, Quality of Life 
Indicators, and Life Satisfaction Among Elderly African Americans, 8 
CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOL. 224, 225 (2002) 
[hereinafter Race-Related Stress] (explaining that racism has been associated 
with stress-related diseases such as hypertension, coronary heart disease, and 
cancer, as well as psychological ailments including depression). 
 97. See Deidre Franklin-Jackson & Robert T. Carter, The Relationships 
Between Race-Related Stress, Racial Identity, and Mental Health for Black 
Americans, 33 J. BLACK PSYCHOL. 5, 6 (2007) (noting studies that linked 
racism to various psychological symptoms and the hypothesis among scholars 
and researchers that Blacks may experience racism as a chronic or life event 
stressor); Hope Landrine et al., Conceptualizing and Measuring Ethnic 
Discrimination in Health Research, 29 J. BEHAV. MED. 79, 79 (2006) (stating 
that “[m]inorities who perceive and report individual-level ethnic 
discrimination have more physical and psychiatric symptoms and problematic 
health behaviors than their White and than their no-discrimination minority 
cohorts”); Chalsa M. Loo et al., Measuring Exposure to Racism: Development 
and Validation of a Race-Related Stressor Scale (RRSS) for Asian American 
Vietnam Veterans, 13 PSYCHOL. ASSESSMENT 503, 525 (2001); Utsey et al., 
Effect of Ethnic Group Membership, supra note 96, at 366–67 (noting that 
African Americans have higher measures of race-related stress than Whites 
and Asians); . 
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stress levels.98 Nevertheless, several comparative studies 
“found that self-reported racism was related to ill-health for 
African Americans and Latinos/as, but not [w]hites.”99 Other 
studies found inverse associations, leading one researcher to 
conclude that “the association between self-reported racism and 
health-related outcomes for studies that included [w]hite 
participants is comparable with the findings of studies 
involving other ethnic/racial groups.”100 
While factors like intensity, frequency, and duration of the 
stressor can affect negative outcomes,101 further research is 
needed to determine whether racism is analogous to other 
stressors,102 whether there is an association between mature 
stages of racial identity and less race-related stress,103 and 
whether racial identity may modify the association between 
self-reported racism and ill health.104 Research also is needed 
to determine the additional long-term effects of race-related 
stress.105 Further illustrating the complexity of race in 
biomedicine, researchers acknowledge problems in 
conceptualizing and measuring racism.106 
While early stress studies focused on health disparities 
between different ethno-racial groups, new research suggests 
that there are also differences within each racial group.107 
Thus, some commentators suggest that future research should 
consider both the differences between and within groups to 
determine whether ethnicity is “a moderating factor in the 
 98. Paradies, supra note 93, at 891. 
 99. Id. 
 100. Id. at 893. 
 101. Williams & Mohammed, supra note 93, at 35–38. 
 102. Id. at 33. 
 103. Franklin-Jackson & Carter, supra note 97, at 18–19. 
 104. Paradies, supra note 93, at 893. 
 105. Utsey et al., Race-Related Stress, supra note 96, at 231 (stressing that 
professionals need to understand how racism as a chronic stressor affects 
quality of life). While coping strategies and socialization are specified by Utsey 
et al. as potential medicating factors, in another article, Utsey mentions a 
positive association between ethnic identity and quality of life. See Utsey et 
al., Effect of Ethnic Group Membership, supra note 96, at 374. 
 106. See Brondolo et al., supra note 93, at 3 (“One of the most challenging 
issues in the study of racism has been its conceptualization and   
measurement . . . . Therefore, studies contrasting the prevalence and health 
effects of different categories of racism/ethnic discrimination are also needed, 
and this will require alterations in approaches to conceptualizing and 
measuring racism.”). 
 107. Id. 
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relationship of psychosocial stressors, such as racism, to health 
outcomes.”108 These commentators also suggest that future 
studies focus on different categories of racism (cultural, 
institutional, individual) and the varying contexts in which 
racism occurs.109 
The stress studies literature suggests that under some 
circumstances self-identified ethno-race, even though socially 
constructed, may be valid as a measure in scientific research. 
But even here, simplistic ethno-racial categories are inadequate 
measures. Following early studies that found “perceived racial 
discrimination contributed significantly to psychiatric 
symptoms among African Americans,” some researchers looked 
for a reliable way to measure perceived racial 
discrimination.110 Each of these measures acknowledges that 
stress resulting in physical and mental illness is not triggered 
by social race alone, but is heavily linked to individual 
perceptions of race, the extent of racial and cultural self-
identification, and how individuals experience and process 
racist or discriminatory behavior. Further, the stress response 
to racism and discrimination is associated with psychological 
and physiological reactions such as anxiety and paranoia, and 
the physiological responses primarily involve the immune, 
 108. Id. Examples of psychophysiological reactivity cited were cortisol, 
blood pressure, and heart rate responses. Id. at 4. 
 109. Id. at 4. For additional commentary on the need for future research in 
this area, see David R. Williams et al., The Concept of Race and Health Status 
in America, 109 PUB. HEALTH REP. 26 (1994) (discussing the potential effects 
of racism and racial discrimination on health outcomes, particularly stress and 
hypertension, and the need for further research). 
 110. Loo et al., supra note 97, at 503–04. A proposed Race-Related Stressor 
Scale (RRSS) created three categories of race-related stressors: (1) racial 
prejudice and stigmatization (direct experiences of perceived discrimination or 
exclusion), (2) bicultural identification and conflict (identifying with a racial or 
ethnic minority and culture), and (3) racist environment (witnessing racist or 
discriminatory behavior). Id. at 504–05. The study applied this measure to 
Asian American Vietnam veterans finding that exposure to one, or a 
combination of, the three categories above contribute to Post Traumatic Stress 
Disorder (PTSD) and general psychiatric symptoms. Id. at 514–15. Another 
research group, concerned about the failure of early stress studies to measure 
the frequency and appraisal of stressful events offered another measure, the 
General Ethnic Discrimination Scale (GEDS) that looks at both frequency and 
appraisal of discriminatory events across all ethnic groups based on the stress 
coping model. Landrine et al., supra note 97, at 80–81. Still another research 
group used the Index of Race-Related Stress (IRRS) that in its “brief version” 
measures cultural, institutional, and individual racism. Utsey et al., Effect of 
Ethnic Group Membership, supra note 96, at 370. 
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neuroendocrine, and cardiovascular systems.111 
Ethnic group membership was found to have a statistically 
significant effect on race-related stress, ethnic identity score, 
and quality of life scores. African Americans had higher scores 
for race-related stress, ethnic identity, and the psychological 
well-being subscale of the quality of life measure. The results 
further indicated that racial identity and cultural racism stress 
both significantly predicted qualities of life. As might be 
expected, cultural racism was inversely related to quality of 
life. Notably, one study indicated that ethnic identity was the 
best predictor of quality of life, which implies that ethnic 
identity is related to psychological and physical health.112 
Thus, studies on race-related stress that only take race into 
account would be, according to these articles, fatally flawed. 
Future studies need to account for a range of other factors that 
can affect how race-related stress impacts individuals. Such 
factors should include socialization, coping strategies, cultural 
identity, individual perception, types of racism, environmental 
factors, and traditional stressors. 
As the race-related stress studies suggest, descriptive race 
in its crudest form may overlook important differences within 
categories. Even if stress is a circumstance where ascriptive 
ethno-race may contribute to a medical outcome, it is important 
to look at other contributing factors. Thus, more thoughtful use 
of ethno-race as either a descriptor or ascriptor should be the 
goal of any biomedical research-related guideline or regulation. 
In their critiques of race’s relevance in biomedical research, 
Braun, Ellison, and their co-authors acknowledge the potential 
influence that biomedical journals have on the use of ethno-
racial categories.  They point out that journals approach this 
question from one of three perspectives. Some journals accept 
self-identified race or ethnicity as an acceptable proxy for 
genetic makeup, others state that race should not be used in 
genetic research because of the genetic variation within self-
identified populations, and still others adopt a middle position 
whereby race can be used to ensure diversity in studies, but not 
as a proxy for genetic variation.113 Braun et al. cite a recent 
 111. Utsey et al., Effect of Ethnic Group Membership, supra note 96, at 368. 
Previous studies found that the psychological effects of stress include anxiety 
and paranoia, and the physiological responses primarily involve the immune, 
neuroendocrine, and cardiovascular system. Id. 
 112. Id. at 372–75. 
 113. Braun et al., supra note 15, at 1424. 
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study finding that “commonly used ethnic labels are both 
insufficient and inaccurate representations of the inferred 
genetic clusters, and that drug-metabolizing profiles . . . differ 
significantly among the clusters.”114  Ellison et al. advocate 
advancing their proposal through biomedical journals, noting, 
however, that some journals are resistant to guidelines, and 
that the guidelines have not significantly affected the content 
of the journals that do have them.115  Recently a few high-
impact medical journals stepped into this debate. The next 
section examines and critiques both medical journal and 
federal guidelines on the use of ethno-race in biomedical 
research. 
III. GUIDELINES ON RACE AND ETHNICITY 
A. JOURNAL GUIDELINES 
Some experts agree with Braun and Ellison about the role 
high impact scientific journals can play in discouraging the 
misuse of race in medical research, but they disagree about the 
goal and focus of journal guidelines. Stacie Geller et al., for 
example, argue that these journals need to adapt their editorial 
guidelines to reinforce the importance of greater compliance 
with federal guidelines aimed at promoting more diversity 
among clinical study participants.116 Fausto-Sterling, on the 
other hand, advocates even stronger measures. She argues that 
 114. Id. at 1424 (internal citations omitted). 
 115. Ellison et al., supra note 72, at 1436.  According to the authors, “648 
journals signed up to the [sic] International Committee of Medical Journal 
Editors’ Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals: Writing and Editing for Biomedical Publication, which recommend 
that ‘When [sic] authors use variables such as race or ethnicity, they should 
define how they measured the variables and justify their relevance.’” Id. 
Ellison et al. call for an international consensus in the biomedical community 
to support guidelines that (1) improve racial and ethnic categories as 
descriptive factors; (2) advocate for the inclusion of specific genotypical, 
cultural, and structural attributive factors; and (3) “generat[e] evidence from 
population studies of racial and ethnic groups that can be used to improve the 
care of individual patients from these groups across different social and 
clinical contexts.” Id. 
 116. See Stacie E. Geller et al., Adherence to Federal Guidelines for 
Reporting of Sex and Race/Ethnicity in Clinical Trials, 15 J. WOMEN’S 
HEALTH 1123, 1130–31 (2006). The authors also argue that funding agencies 
must engage in greater scrutiny of the clinical trials they support to ensure 
equitable enrollment among gender and race/ethnicity. Id. 
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editors of scientific journals and those who review articles for 
these journals should require that researchers define and 
justify their use of racial categories, especially since other 
factors like socioeconomic status, geography, and individual life 
cycle may be better predictors of specific disease patterns.117 
To date, three major English language scientific academic 
publications, the British Medical Journal, Nature Genetics and 
the Journal of the American Medical Association, have 
announced guidelines on the use of race and ethnicity in 
medical research. With the exception of Nature Genetics, these 
journal guidelines are aspirational, not mandatory. A fourth 
journal, the New England Journal of Medicine, entertained a 
debate on the subject but adopted no guidelines. Most 
guidelines advocate for increased clarity in why ethno-race is 
being considered, the rationale behind the ethno-racial 
groupings, and the method of subject assignment. This section 
critiques these guidelines to determine whether any contain 
useful restrictions Congress might adopt to discourage the 
inappropriate use of ethno-race in federally funded bio-medical 
research. 
The Journal of the American Medical Association (JAMA) 
is the only journal to expressly advocate the use of self-
identified race in biomedical research.118 According to Margaret 
Winkler, Deputy Editor of JAMA, the guidelines elaborate on 
and clarify the published guidelines of the International 
Committee of Medical Journal Editors (CMJE) that advise 
authors who use ethno-racial variables to “define how they 
measured the variables and justify their relevance.”119 The 
JAMA guidelines add that “authors should describe who 
designated race and/or ethnicity for an individual” and also 
note that “self-designation generally is preferred.”120 Rather 
than discourage the use of ethno-racial labels in research, the 
JAMA guidelines support subject self-identification of ethno-
racial identity that, as mentioned previously and discussed 
 117. Fausto-Sterling, supra note 4, at 670. 
 118. Margaret A. Winkler, Editorial, Measuring Race and Ethnicity: Why 
and How?, 292 J. AM. MED. ASS’N 1612, 1614 (2004). 
 119. Id. (citing INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL 
EDITORS, UNIFORM REQUIREMENTS FOR MANUSCRIPTS SUBMITTED TO 
BIOMEDICAL JOURNALS: WRITING AND EDITING FOR BIOMEDICAL PUBLICATION, 
sec. IV.A.6.a (updated Nov. 2003), http://www.icmje.org/#prepare). The CMJE 
guideline statement emphasizes the need for clarity in racial categorization. 
Id. 
 120. Id. (emphasis added). 
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below, is a poor proxy for genetic variation.121 
One example of why self-identification of ethno-racial 
identity is a poor proxy for genetic variation lies in the fact that 
a subject’s self-identified ethno-racial status may be different 
from that individual’s bio-geographic ancestry based “on a 
range of historical, cultural and sociopolitical factors.”122 My 
friend, for example, self-identifies as black (remote African 
ancestry), while her bio-geographic ancestry may more strongly 
correspond to her remote European ancestry. Thus, self-
identification as a method to assign ethno-racial categories 
(and sometimes inappropriately infer genetic makeup) is 
limited because it may only provide a partial view of the 
individual’s geographic genetic ancestry.123 Nevertheless, self-
identified race and bio-geographic ancestry are important in 
studying health disparities.124 
Second, the JAMA guidelines state that “[a]uthors should 
indicate whether the options for [racial and ethnic] designation 
were closed or open.”125 Winkler notes that while open-ended 
options potentially provide a more accurate description of 
individual ethno-racial identity, open-ended self-reported 
ethno-race is difficult to categorize for research purposes.126 
Knowing, for example, that a clinical subject self-identifies as 
having Hawaiian, Chinese, English, and Korean ancestry helps 
establish the diversity of enrollees, but outside of a study of 
populations in Hawaii this level of self-identification will result 
in too small a sample group to provide researchers with useful 
information. Unfortunately, Winkler offers no solutions for 
dealing with problematic open-ended options. 
The JAMA guidelines further suggest that researchers 
should make ethno-racial coding in studies more “transparent” 
by disclosing the options for racial categories used by 
researchers, how these options were established, and what 
 121. See Caulfield et al., supra note 18, at 8.2. For a discussion of this 
point, see supra footnotes 17, 28, 84 and accompanying text. 
 122. Sandra Soo-Jin Lee et al., The Ethics of Characterizing Difference: 
Guiding Principles on Using Racial Categories in Human Genetics, 9 GENOME 
BIOLOGY 404, 404.2 (2008) (Statement 3). 
 123. Id. at 404.2. 
 124. Id. 
 125. Winkler, supra note 118, at 1614. The guideline continues: “If the 
options were closed, authors are asked to provide what the options were, 
whether categories were combined, and, if so, how.” Id. 
 126. Id. 
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subcategories are included in the study.127 Thus, this guideline, 
which seems to favor closed option ethno-racial designations for 
coding purposes, undercuts the first and supposed primary 
guideline goal, clarity in racial categorization. 
Clarity in ethno-racial designations is also relevant in 
monitoring who has access to clinical studies, a point addressed 
in part by the last JAMA guideline, which states that authors 
should justify why they believe ethno-race is “relevant to the 
particular study.”128 The goal of this guideline is to encourage 
researchers to more critically consider the relevance of ethno-
race as factors in their study129 or, in other words, to analyze 
whether the ascriptive use of ethno-race is appropriate. Thus, 
JAMA encourages researchers to directly measure other social 
and environmental factors as causes.130 
By not renouncing the use of race as a proxy for genetic 
similarity, the JAMA guidelines, while an improvement, only 
hint at the potential for misuse of ethno-racial labels in 
research. Under the guideline, race is a permissible proxy for 
other difficult to measure variables, so long as the rationale for 
doing so is clearly stated.131 Yet Winkler cites no examples of 
situations where race would be an acceptable substitute for 
these difficult to measure and unspecified variables, a 
troublesome omission. 
Further, Winkler’s reasoning seems circular. She concedes 
that race is a social construct with little or no scientific value 
but argues that ethno-racial self-identification may have some 
unspecified value in biomedical research. Because the JAMA 
guidelines provide little real guidance researchers are likely to 
continue following old familiar patterns, relying on older 
studies that used race inappropriately. 
As mentioned earlier, the British Medical Journal (BMJ) 
was the first high impact medical journal to publish guidelines 
 127. Id. 
 128. Id. (noting that the authors should state their rationale if they use 
race or ethnicity as proxies for unknown, or hard to measure variables and 
providing the following examples of social and environmental factors that 
should be measured directly: “socioeconomic status, education, urban vs. rural 
location, or income region by zip code”). 
 129. Id. 
 130. Id. (instructing the researcher to “determine whether an outcome is 
truly related to ethno-race (as defined by the study) or to other factors with a 
closer relationship to the causal pathway”). 
 131. Id. (identifying variables such as socioeconomic status, education, 
urban versus rural locations, or income region by ZIP code). 
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on the use of ethno-race in biomedical research. The journal 
offers three major guidelines with the first two meant to 
encourage authors to explain “the logic behind their ‘ethnic’ 
groupings.”132 First, the journal urges authors “to use accurate 
descriptions” when employing ethno-racial terminology.133 In 
explaining the need for these guidelines, BMJ discusses how 
ethno-race terminology is subject to culture, political debates 
and imperatives.134 Since ethno-race terms are forever 
changing, the journal reasons, authors should provide 
descriptions with racial terminology so that future researchers 
will be able to more reliably compare past results to future 
ones.135 
Secondly, BMJ announced that, henceforth, racial or ethnic 
descriptions should reference the method behind these 
groupings.136 Thus, BMJ encourages specific descriptions of 
ethno-racial categories, as well as a notation of how the 
groupings were assigned. As an example of the first two 
guidelines, BMJ used the ethno-racial self-identified label 
“black Caribbean” instead of “black.”137 
The third guideline provides that any ethno-racial 
“[c]ategorisation . . . should relate to the type of hypothesis 
under investigation.”138 BMJ notes that “race has limited 
biological validity,”139 thus categories based on genetic make-
up, for example, should be used ascriptively in studies 
assessing health risks, whereas ethno-racial categories may be 
more helpful descriptively in studies assessing health services. 
If researchers do not know which, among race, ethnicity, or 
culture, will be the most powerful determinant of the outcome, 
BMJ advises them to measure each factor.140 Thus, BMJ 
encourages researchers to collect a range of information, 
including genetic differences, self-assigned ethnicity, observer-
assigned ethnicity, country or area of birth, years in country of 
 132. Editorial, Ethnicity, Race, and Culture: Guidelines for Research, 
Audit, and Publications, 312 BRIT. MED. J. 1094 (1996). 
 133. Id. 
 134. Id. 
 135. Id. 
 136. Id. 
 137. Id. 
 138. Id. 
 139. Id. 
 140. Id. 
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residence, and religion.141 These guidelines aim at ensuring 
that biomedical research is more comparable in the future.142 
Whereas JAMA and BMJ published their guidelines 
hoping that authors would try to follow them, only one journal, 
Nature Genetics, stated that their guidelines are mandatory.143 
In an editorial describing the new guidelines, Nature Genetics 
discussed how the 2000 U.S. Census, in an effort to address the 
nation’s increasing diversity, included an option for “Other 
Race.”144 The editorial explains that this option allows 
individuals to self-select more than one ethno-racial category 
and will create “63 possible permutations.”145 The editorial goes 
on to acknowledge that in most scientific communities, “race” is 
not a scientific term.146 Nature Genetics then states, however, 
that ethno-race may be a valid variable in scientific studies as a 
proxy for discriminatory experiences, diet, or other 
environmental factors, but it should not be used as a substitute 
for measurable parameters such as genetic variation or 
differences in metabolism.147 
Nature Genetics’ goal in mandating journal guidelines is to 
“raise awareness and inspire more rigorous design of genetic 
and epidemiological studies.”148 Going forward, Nature Genetics 
will require authors to explain the reason for their use of 
specific ethno-racial groups and how that classification was 
achieved.149 The hope is that these guidelines will encourage 
researchers to find ways to improve the health of populations 
 141. Id. (explaining that, to determine genetic differences, research should 
use “relevant genetically determined polymorphism,” that “nationally agreed 
guidelines” should be used to determine self-assigned ethnicity” thereby 
“enabling comparability with census data,” that “observer-assigned ethnicity” 
should use “OPCS or other national census categorisation or the researchers’ 
own logically argued categories,” and “country or area of birth” should be 
determined by using “the subject’s own, or parents’ and grandparents’ if 
applicable”). 
 142. Id. 
 143. Editorial, Census, Race and Science, 24 NATURE GENETICS 97, 98 
(2000). 
 144. Id. at 97. 
 145. Id. at 97. 
 146. Id. at 97–98 (referencing the AAA’s 1997 recommendation that the 
U.S. government stop using race in collection of data because race is a social 
not a scientific concept). 
 147. Id. at 98. 
 148. Id. 
 149. Id. 
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without using ethno-race as a “pseudo-biological” variable.150 
In 2001, the New England Journal of Medicine (NEJM) 
entertained a debate about the use of ethno-race in biomedical 
research, but stopped short of imposing guidelines. Instead, it 
published a powerful editorial by Dr. Robert S. Schwartz, a 
deputy editor of NEJM, criticizing the uncritical use of race in 
research.151 He also encourages all journals to adopt the Nature 
Genetics guidelines on the use of racial and ethnic categories in 
medical research.152 
In his editorial, Dr. Schwartz cites two articles published 
in the same issue that use race inappropriately.153 Like others, 
he believes that any study using ethno-racial categories “should 
begin with a plausible, clearly defined, and testable hypothesis” 
which considers the relevance of these categories.154 A better 
approach, according to Dr. Schwartz, is to focus on genetic 
variations, rather than ethno-racial differences.155 He reasons 
that the genetic similarities across ethno-race categories 
reported by the human genome project “should force an end to 
medical research that is arbitrarily based on race.”156 
Reflecting the ongoing debate about the use of race in 
biomedical research, Dr. Schwartz’s editorial was countered by 
another editorial “praising” the use of race in medical 
research.157 The debate in NEJM continued in 2003 when the 
journal published another pair of articles for and against the 
 150. Id. 
 151. Robert S. Schwartz, Racial Profiling in Medical Research, 344 NEW 
ENG. J. MED. 1392, 1392–93 (2001). 
 152. Id. at 1393. 
 153. Id. at 1392 (citing Clyde W. Yancy et al., Race and the Response to 
Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure, 
344 NEW. ENG. J. MED. 1358–65 (2001) (reporting that carvedilol, a beta 
blocker, has a similar benefit in blacks and nonblacks with chronic heart 
failure) and Derek V. Exner et al., Lesser Response to Angiotensin-Converting-
Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left 
Ventricular Dysfunction, 344 N. ENGL. J. MED. 1351, 1351–57 (2001) (claiming 
that enalapril, an angiotension-converting-enzyme inhibitor, is more effective 
when used in whites with left ventricular dysfunction than in blacks)). 
 154. Id. at 1393. 
 155. Id. at 1393. 
 156. Id. at 1393. See sources cited supra note 17. 
 157. Lillquist & Sullivan, supra note 29, at 394 (citing Alastair J.J. Wood, 
Racial Differences in the Response to Drugs—Pointers to Genetic Differences, 
344 NEW ENG. J. MED. 1393 (2001) (favoring the use of race)). 
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uncritical use of race in research.158 The question of NEJM 
guidelines in this area remains unresolved to this day. 
The journal guidelines discussed above are generally 
similar to the recommended guidelines announced in 2008 by a 
multi-disciplinary group from Stanford University (the 
Stanford Group159).160 Although the Stanford Group’s 
guidelines regarding the use of ethno-racial categories were 
developed for use in research exploring “human genetic 
variation,”161 they seem equally applicable to biomedical 
research. In some respects, the Nature Genetics guidelines are 
almost identical to provisions of the Stanford Group guidelines. 
Nature Genetics, for example, requires authors to “explain why 
they make use of particular ethnic groups or populations, and 
how classification was achieved.”162 Similarly, the Stanford 
Group encourages researchers to “describe how individual 
samples are assigned category labels, [and] to explain why 
samples with such labels were included in the study.”163 
Unfortunately, however, the Nature Genetics guidelines, like 
the guidelines proposed by JAMA and BMJ, fail to address the 
myriad of other issues surrounding racial categorization 
presented in the Stanford Group model. 
More specifically, the Stanford Group recommends that 
researchers, when considering whether to use ethno-race as a 
factor in a study, ask themselves three questions: (1) why race 
or ethnicity is relevant to the study, (2) how race or ethnicity is 
to be determined, and (3) whether the ethno-racial categories 
are variables in the research.164 Thus rather than construct a 
 158. Id. (referencing Esteban González Burchard et al., The Importance of 
Race and Ethnic Background in Biomedical Research and Clinical Practice, 
348 NEW ENG. J. MED. 1170 (2003) (favoring the use of race) and Richard S. 
Copper et al., Race and Genomics, 348 NEW ENG. J. MED. 1166 (2003) 
(opposing the use of race)). 
 159. The Stanford Group consists of “faculty from the humanities, social 
sciences, life sciences, law, and medicine.” Lee et al., supra note 122, at 404.1. 
 160. Compare, e.g., Census, Race and Science, supra note 143, at 98 
(requiring authors to “explain why they make use of particular ethnic groups 
or populations, and how classification was achieved”) with Lee et al., supra 
note 122, at 404.2 (encouraging researchers to “describe how individual 
samples are assigned category labels, [and] to explain why samples with such 
labels were included in the study”). 
 161. Lee et al., supra note 122, at 404.1. 
 162. Editorial, supra note 143, at 98. 
 163. Lee et al., supra note 122, at 404.2. 
 164. Id. (suggesting that in order to design a research protocol that 
minimizes the “use of science for racial stereotyping,” researchers can “assess 
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study of cancer rates among ethno-racial groups, the Stanford 
Group argues that it might be more appropriate to construct a 
study of cancer rates based on age or gender that also records 
the ethno-race of subjects. Other researchers also agree with 
the Stanford Group about the importance of education in 
remedying the problem.165 Dr. Schwartz, for example, writes 
that educating academics and researchers about “the fallacy of 
race as a scientific concept”, is an especially important 
component in preventing misuse of race in medical research.166 
BMJ’s guidelines have had mixed results. BMJ published 
sixteen post-guideline studies between 2000 and 2009 that 
considered race or ethnicity.167 Four studies clearly meet the 
the purpose and impact of using racial and ethnic categories in their research 
and investigate whether alternative approaches would be appropriate”). But 
see Dale E. Hammerschmidt, It’s as Simple as Black and White! Race and 
Ethnicity as Categorical Variables, 133 J. LABORATORY & CLINICAL MED. 10, 
11 (1999) (suggesting that race should be treated the same as other categorical 
variables by: identifying what about race may be important to the study 
[which often leads to a more appropriate socioeconomic variable]; establishing 
criteria for subject assignment, and applying such criteria consistently, in an 
organized manner; and emphasizing clarity in the method of subject 
assignment and awareness of the potential misuse of study findings). 
 165. Schwartz, supra note 151, at 1393; see also Lee et al., supra note 122, 
at 404.3 (arguing for the genetics curriculum to include a history of the use of 
science to further racist theories and policies). 
 166. Schwartz, supra note 151, at 1392. 
 167. Imelda Balchin et al., Racial Variation in the Association Between 
Gestational Age and Perinatal Mortality: Prospective Study, 334 BRIT. MED. J. 
833 (2007); J. Boydell et al., Incidence of Schizophrenia in Ethnic Minorities in 
London: Ecological Study into Interactions with Environment, 323 BRIT. MED. 
J. 1336 (2001); Annie Britton et al., Does Access To Cardiac Investigation and 
Treatment Contribute to Social and Ethnic Differences in Coronary Heart 
Disease? Whitehall II Prospective Cohort Study, 329 BRIT. MED. J. 318 (2004); 
Francesco P. Cappuccio et al., Application of Framingham Risk Estimates to 
Ethnic Minorities in United Kingdom and Implications for Primary Prevention 
of Heart Disease in General Practice: Cross Sectional Population Based Study, 
325 BRIT. MED. J. 1271 (2002); Desiree M.A. Choi et al., Ethnicity and 
Prescription of Analgesia in an Accident and Emergency Department: Cross 
Sectional Study, 320 BRIT. MED. J. 980 (2000); Gene Feder et al., Ethnic 
Differences in Invasive Management of Coronary Disease: Prospective Cohort 
Study of Patients Undergoing Angiography, 324 BRIT. MED. J. 511 (2002); Nick 
Freemantle et al., What Factors Predict Differences in Infant and Perinatal 
Mortality in Primary Care Trusts in England? A Prognostic Model, 339 BRIT. 
MED. J. 2892 (2009); Julia Hippisley-Cox et al., Association of Deprivation, 
Ethnicity, and Sex with Quality Indicators for Diabetes: Population Based 
Survey of 53,000 Patients in Primary Care, 329 BRIT. MED. J. 1267 (2004) 
[hereinafter Hippisley-Cox et al. I]; Julia Hippisley-Cox et al., Predicting Risk 
of Type 2 Diabetes in England and Wales: Prospective Derivation and 
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BMJ guidelines,168 if the census categories provide adequate 
description of the ethno-racial categories.169 In five other 
studies, it is unclear whether the first guideline recommending 
the use of accurate ethno-racial descriptions is actually met. 
Some articles provide no description whatsoever of the ethno-
racial categories beyond the names of the categories 
themselves.170 Thus, while we know what is included in the 
ethno-racial category (i.e., black includes black African, black 
Caribbean, and mixed), the categories in the studies still use 
the broad, non-descriptive terms (i.e., black, white, non-white, 
and Asian) that the guidelines attempted to discourage. 
The most difficult part of the BMJ guidelines is to discern 
whether the ethno-racial categorization in these studies relates 
Validation of QDScore, 338 BRIT. MED. J. b880 (2009) [hereinafter Hippisley-
Cox et al. II]; Marian Knight et al., Inequalities in Maternal Health: National 
Cohort Study of Ethnic Variation in Severe Maternal Morbidities, 338 BRIT. 
MED. J. b542 (2009); Trevor W. Lambert et al., Characteristics of Consultants 
Who Hold Distinction Awards in England and Wales: Database Analysis with 
Particular Reference to Sex and Ethnicity, 328 BRIT. MED. J. 1347 (2004); Kath 
Moser et al., Inequalities in Reported Use of Breast and Cervical Screening in 
Great Britain: Analysis of Cross Sectional Survey Data, 338 BRIT. MED. J. 
b2025 (2009); Sonia Saxena et al., Socioeconomic and Ethnic Group 
Differences in Self Reported Health Status and Use of Health Services by 
Children and Young People in England: Cross Sectional Study, 325 BRIT. MED. 
J. 520 (2002); Jane Wardle et al., Development of Adiposity in Adolescence: 
Five Year Longitudinal Study of an Ethnically and Socioeconomically Diverse 
Sample of Young People in Britain, 332 BRIT. MED. J. 1130 (2006); Peter H. 
Whincup et al., Early Evidence of Ethnic Differences in Cardiovascular Risk: 
Cross Sectional Comparison of British South Asian and White Children, 324 
BRIT. MED. J. 635 (2002); Katherine Woolf et al., Ethnic Stereotypes and the 
Underachievement of UK Medical Students from Ethnic Minorities: Qualitative 
Study, 337 BRIT. MED. J. a1220 (2008). 
 168. Hippisley-Cox et al. II, supra note 167; Knight et al., supra note 167; 
Saxena et al., supra note 167; Woolf et al., supra note 167. 
 169. U.K. census categories are as follows: White (includes options for 
British, Irish, or any other white background), mixed (includes options of 
White and Black Caribbean, White and Black African, White and Asian, or 
any other mixed background), Asian or Asian British (includes options for 
Indian, Pakistani, Bangladeshi, any other Asian background), Black or Black 
British (includes options for Caribbean, African, any other black background), 
Chinese or other ethnic group (includes options for Chinese, or write-in for 
other ethnic group). OFFICE FOR NAT’L STATISTICS, EXEC. OFFICE OF THE UK 
STATISTICS AUTHORITY, CENSUS 2001 FORM: ENGLAND HOUSEHOLD FORM 
(2001), available at http://www.statistics.gov.uk/census2001/pdfs/engh1.pdf. 
 170. Balchin et al., supra note 167; Boydell et al., supra note 167; Britton 
et al., supra note 167; Cappuccio et al., supra note 167; Choi et al., supra note 
167; Feder et al., supra note 167; Freemantle et al., supra note 167; Hippisley-
Cox et al. I, supra note 167; Lambert et al., supra note 167; Moser et al., supra 
note 167; Wardle et al., supra note 167; Whincup et al., supra note 167. 
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to the type of hypothesis under investigation. According to the 
guidelines, “race has little biological validity”;171 therefore, if 
the studies were looking for biological differences, they should 
have used categories based on genetic variation, not race. If the 
studies were merely looking for racial disparities in quality and 
access to health care, or the impact of social and environmental 
factors on health outcomes, then ethno-racial categories may be 
appropriate. Several articles seemed to use race this way,172 
but a few articles seem to be looking for biological difference 
and, therefore, used ethno-racial categories inappropriately.173 
Only one of four identified studies published in Nature 
Genetics from 2000 to 2009 seems to meet the criteria 
established by that journal.174 Two of the three remaining 
studies meet one of the two guidelines, but differ as to which 
guideline was met.175 The last study does not seem to meet 
either guideline.176 Thus, there is no real pattern as to how 
authors use or disregard the Nature Genetics guidelines.177 
While all of the journal guideline statements mentioned 
above are promising developments, without stringent oversight, 
there is little incentive for researchers to change their 
methodologies or thinking about ethno-race. Even mandatory 
 171. Ethnicity, Race, and Culture, supra note 132. 
 172. Boydell et al., supra note 167; Britton et al., supra note 167; Choi et 
al., supra note 167; Feder et al, supra note 167; Freemantle et al., supra note 
167; Hippisley-Cox et al. I, supra note 167; Hippisley-Cox et al. II, supra note 
167; Knight et al., supra note 167; Lambert et al., supra note 167; Moser et al., 
supra note 167; Saxena et al., supra note 167; Woolf et al., supra note 167. 
 173. These studies seem to use ethno-race inappropriately: Cappuccio et al, 
supra note 167; Whincup et al., supra note 167. It is unclear whether the 
following studies use race inappropriately: Balchin et al., supra note 167; 
Wardle et al, supra note 167. 
 174. John P.A. Ioannidis et al., ‘Racial’ Differences in Genetic Effects for 
Complex Diseases, 36 NATURE GENETICS 1312 (2004). 
 175. Anna Helgadottir et al., A Variant of the Gene Encoding Leukotriene 
A4 Hydrolase Confers Ethnicity-Specific Risk of Myocardial Infarction, 38 
NATURE GENETICS 68 (2006); Richard S. Spielman et al., Common Genetic 
Variants Account for Differences in Gene Expression Among Ethnic Groups, 39 
NATURE GENETICS 226 (2007). 
 176. E.J. Parra et al., Implications of Correlations Between Skin Color and 
Genetic Ancestry for Biomedical Research, 36 NATURE GENETICS S54 (2004). 
 177. Although the journal guidelines are intended for clinical studies, two 
commentaries published in Nature Genetics seem to partially meet the 
guidelines. See David B. Goldstein & Joel N. Hirschhorn, In Genetic Control of 
Disease, Does ‘Race’ Matter?, 36 NATURE GENETICS 1243 (2004); Hua Tang, 
Confronting Ethnicity-Specific Disease Risk, 38 NATURE GENETICS 13 (2006). 
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guidelines, like those established by Nature Genetics, are not 
always enforced. The federal guidelines on ethno-racial 
categories are equally problematic, but for different reasons, a 
point explored in next section. 
B. FEDERAL GUIDELINES ON ETHNO-RACE IN BIOMEDICAL 
RESEARCH 
Although life expectancy and overall health for all 
Americans improved substantially in the twentieth century, 
significant health disparities remained, especially among racial 
and ethnic minority communities.178 As a result, in 1998 
President Clinton proposed a twelve-year plan to end health 
disparities in six areas.179 The Clinton effort was one of many 
national attempts to address health disparities among 
Americans.180 Similar efforts continue to this day, as the 
National Institute on Minority Health and Health Disparities 
(NIMHD) “leads, coordinates, supports and assesses the NIH 
 178. David Satcher, Our Commitment to Eliminate Racial and Ethnic 
Health Disparities, 1 YALE J. HEALTH POL’Y L. & ETHICS 1, 1 (2001). 
 179. Id. at 2 (“President Clinton committed . . . to eliminate the disparities 
experienced by racial and ethic minority populations in six health-related 
areas, including cancer screening and management, cardiovascular disease, 
diabetes, HIV/AIDS, immunization rates, and infant mortality.”). 
 180. Id. (“Clinton’s goal parallel[ed] the focus of Healthy People 2010—the 
nation’s health objectives for the twenty-first century—which Donna Shalala, 
former Secretary of the U.S. Department of Health and Human Services 
(DHHS) . . . released in January 2000.”). In 1986, the Office of Minority Health 
(OMH) was created to “improve health and healthcare outcomes for racial and 
ethnic minority communities by developing or advancing policies, programs, 
and practices that address health, social, economic, environmental and other 
factors which impact health.” About OMH, The OFFICE OF MINORITY HEALTH, 
http://minorityhealth.hhs.gov/templates/browse.aspx?lvl=1&lvlID=7 (last 
visited Mar. 2, 2011); see also Jeffrey Brainard, Debate Over Improving 
Minority Health Pits NIH Director Against Black Leaders, CHRON. HIGHER 
EDUC., Sept. 10, 1999, at A41. In 1992 the Office of Research on Minority 
Health (ORMH) unveiled the Minority Health Initiative (MHI), consisting of a 
multi-year biomedical and behavioral research and research training program 
designed to “improve prenatal health and reduce infant mortality,” fund 
“studies of childhood and adolescent lead poisoning, HIV infection and AIDS, 
and alcohol and drug abuse,” conduct “research in adult populations focused 
on cancer, diabetes, obesity, hypertension, cardiovascular diseases, mental 
disorders, asthma, visual impairments, and alcohol abuse,” and train “faculty 
and . . . students at all stages of the educational pipeline.” Press Release, Nat’l 
Insts. of Health, Office of Research on Minority Health (Apr. 14, 2000), 
available at http://www.nih.gov/news/pr/apr2000/od-14.htm; The NIH 
Almanac, NAT’L INSTS. OF HEALTH, 
http://www.nih.gov/about/almanac/organization/NIMHD.htm (last visited Dec. 
17, 2010). 
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research effort to reduce and ultimately eliminate health 
disparities” as they affect racial and ethnic communities and 
medically underserved individuals.181 
Unfortunately, these well-intended legislative attempts to 
encourage greater study of minority health send confusing 
signals to researchers. As Dorothy Roberts points out, the 
federal funding guidelines create a paradox: guideline 
measures designed to remedy past discrimination and 
exclusion in biomedical research based on ethno-racial labels 
actually require race consciousness.182 This form of race-
consciousness, however, risks “reinforcing biological definitions 
of race that have historically legitimized racial inequalities.”183 
Thus, then-U.S. Surgeon General Dr. David Satcher, a black 
physician, had to remind readers in the supplement to a 
comprehensive 1999 federal report on mental health that the 
term “race” as used in that report referred to “social 
characteristics held in common, such as general societal 
treatment and access to resources,” and not purported 
 181. The NIH Almanac, supra note 180. The Institute was, until recently, 
the National Center on Minority Health and Health Disparities. See Press 
Release, Nat’l Insts. of Health, NIH Announces Institute on Minority Health 
and Health Disparities (Sept. 27, 2010), available at 
http://www.nih.gov/news/health/sep2010/nimhd-27.htm. The NIH has several 
programs engaged in “medical research concerning racial and ethnic 
minorities” including: the NCMHD which “leads, coordinates, supports and 
assesses the NIH effort to reduce and ultimately eliminate health disparities”; 
Centers for Population Health and Health Disparities, “designed to support 
research to understand and reduce differences in health outcomes, access and 
care”; NIH’s National Health Lung and Blood Institute (NHLBI), which 
“partners with African American communities through Enhanced 
Dissemination and Utilization Centers to implement education and 
intervention programs to cut the rates of CVD risk factors and to promote 
healthy lifestyles.” NHLBI is also conducting the Jackson Heart Study C the 
first large-scale cardiovascular disease study among African Americans to 
examine the factors that influence the diseases development in this 
population. The National Institute of Environmental Health Sciences (NIEHS) 
which is “a leader in the area of understanding how poverty, environmental 
pollution, and health interrelate.” Press Release, U.S. Dep’t of Health & 
Human Servs., Protecting the Health of Minority Communities (Jan. 13, 
2006), available at http://www.hhs.gov/news/factsheet/minorityhealth.html. 
For further information on these and other environmental health programs of 
NIEHS and NIMH, visit http://www.niehs.nih.gov/. and 
http://www.nimhd.nih.gov/. 
 182. Roberts, supra note 17, at 528. 
 183. Id. 
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biological differences.184 
Federal grant application regulations establish guidelines 
and provide incentives for the inclusion of different racial and 
ethnic groups in clinical trials.185 But these guidelines also 
create confusion. Section 5.8 of the Application Guide for NIH 
and Other Public Health Services (PHS) Agencies, for example, 
explains the inclusion guidelines for federally funded 
studies.186 Under this provision, studies funded by these 
federal agencies are required to “identify research subjects by 
race and ethnicity, to include minorities in clinical trials, and . . 
. report their findings according to the racial and ethnic 
identity of research subjects”187 using OMB’s concededly 
socially constructed standards, which contain five racial and 
two ethnic categories.188 
These guidelines, however, seem to ignore OMB’s own 
caveat that “the racial and ethnic categories set forth in the 
standards should not be interpreted as being primarily 
biological or genetic in reference.”189 Moreover, federal 
databases confuse racial and ethnic categories in genetic 
research because samples are organized into categories that 
overlap and/or conflate notions of race, ethnicity, nationality, 
continental geography, and religion.190 Mindful that OMB’s 
categories are overly broad, NIH encourages reporting on 
 184. Matt Boucher, Turning a Blind (White) Eye in Legislating Mental 
Health Parity: The Unmet, Overlooked Needs of the Working Poor in Racial 
and Ethnic Minority Communities, 19 J. CONTEMP. HEALTH L. & POL’Y 465, 
466 n.5 (2003) (citing U.S. DEP’T OF HEALTH & HUMAN SERVS., MENTAL 
HEALTH: CULTURE, RACE, AND ETHNICITY: A SUPPLEMENT TO MENTAL 
HEALTH: A REPORT OF THE SURGEON GENERAL 9 (2001) [hereinafter MHCRE] 
(defining ethnicity as “a common heritage shared by a particular group”)). 
Boucher’s report “uses the term ‘minority’ to ‘signify [a] group[‘s] limited 
political power and social resources, as well as their unequal access to 
opportunities, social rewards, and social status.” Boucher, supra, at 471 n.31 
(citing MHCRE, supra, at 5). 
 185. Jonathan Kahn, Genes, Race, and Population: Avoiding a Collision of 
Categories, 96 AM. J. PUB. HEALTH 1965, 1966 (2006). 
 186. See U.S. DEP’T OF HEALTH & HUM. SERVS., PUBLIC HEALTH SERVICE 
GRANT APPLICATION INSTRUCTIONS § 5.8 (June 2009), available at 
http://grants.nih.gov/grants/funding/phs398/phs398.pdf. 
 187. Roberts, supra note 17, at 529. Roberts also argues that state laws are 
another potential source of regulation. Id. at 530. 
 188. For a critique of the OMB’s standards for reporting race and ethnic 
statistics, see Response to OMB Directive 15, supra note 76. 
 189. Kahn, Genes, Race, and Population, supra note 185, at 1968. 
 190. Id. at 1966–67. 
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ethno-racial categories in greater detail.191 In determining 
ethno-race, NIH also advises researchers to use subject self-
identification,192 which, as this article previously argued, is 
problematic.193 
In addition to the inadequate descriptive racial categories, 
NIH’s enforcement mechanisms are not particularly helpful 
because they focus on problems that arise after the research 
project has received funding.194 Continuation of the grant and 
disbursement of the award depend on the submission of 
periodic reports that must disclose the race and ethnicity of 
human subjects.195 This system of oversight seems to give NIH 
the ability to impose funding restrictions on studies that are 
not following the inclusion guidelines as mandated by federal 
law. 
But the inappropriate use of ethno-race usually appears at 
the grant application stage in the research protocol. Further, 
the follow-up to determine whether researchers complied with 
 191. U.S. DEP’T OF HEALTH & HUM. SERVS., GRANT APPLICATION 
INSTRUCTIONS, supra note 186, at II-20 (“Subpopulations: Each ethnic/racial 
group contains subpopulations that are delimited by geographic origins, 
national origins, and/or cultural differences. It is recognized that there are 
different ways of defining and reporting racial and ethnic subpopulation data. 
The subpopulation to which an individual is assigned depends on self-
reporting of specific origins and/or cultural heritage. Attention to 
subpopulations also applies to individuals who self identify with more than 
one race. These ethnic/racial combinations may have biomedical, behavioral, 
and/or social-cultural implications related to the scientific question under 
study.”). 
 192. Id. The OMB also encourages self-reporting: “respondent self-
identification should be facilitated to the greatest extent possible, recognizing 
that in some data collection systems observer identification is more practical.”  
Recommendations From the Interagency Committee for the Review of the 
Racial and Ethnic Standards to the Office of Management and Budget 
Concerning Changes to the Standards for the Classification of Federal Data on 
Race and Ethnicity, 62 Fed. Reg.  36,873, 36,881 (Jul. 9, 1997), available at 
http://www.whitehouse.gov/sites/default/files/omb/assets/omb/fedreg/ombdir15.
pdf. 
 193. See supra notes 83, 122–123, and accompanying text. 
 194. See NIH GRANTS POLICY STATEMENT (2003), available at 
http://grants1.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part5.htm#_Toc546
00106 (noting that “NIH uses the project period system of funding. Under this 
system, projects are programmatically approved for support in their entirety 
but are funded in annual increments called budget periods.”). 
 195. See Final Progress Report, NIH GRANTS POLICY STATEMENT (2003), 
http://grants1.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part8.htm#_Toc546
00141. 
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their plan is not with the researchers, but with the institutes 
reviewing the proposals, who are required to prepare reports 
“describing the manner in which the institute has complied” 
with the Revitalization Act.196 While the NIH Policy on 
Reporting Race and Ethnicity Data suggests that researchers 
have to complete annual reports of the total enrollment by race, 
ethnicity, and gender, it does not address the consequences if 
researchers fail to comply with this requirement or identify 
race inappropriately.197 
A 2006 study of adherence to federal guidelines for 
reporting race, ethnicity, and sex in federally funded clinical 
trials published in high impact journals in 2004 found that 67% 
of the trials reported the number of black subjects and 48% 
reported the number of Hispanic subjects, while only 18% of 
studies reported nothing with respect to the race/ethnicity of 
their subjects.198 These studies generally did not report results 
by race (which seems appropriate), and the vast majority did 
not acknowledge any limitations on generalizability due to the 
race or ethnicity of the subjects.199 Further, none of the four 
phase III trials provided race-specific results or addressed any 
statistically significant racial/ethnic differences.200 Despite the 
lack of compliance with the guidelines, and resulting lack of 
diversity among trial subjects, the vast majority of studies 
generalized the results to all populations.201 Thus, requiring 
researchers to be race conscious in the selection of clinical 
subjects does not necessarily translate into a reification of race 
in most federally funded studies. 
Another study looked at the use of racial and ethnic 
terminology in genetic research, and whether the use of such 
 196. See NIH Guidelines on the Inclusion of Women and Minorities as 
Subjects in Clinical Research, 59 Fed. Reg. 14,508, 14,510 (Mar. 28, 1994). 
 197. NIH Policy on Reporting Race and Ethnicity Data, NIH (Aug. 8, 2001), 
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html. 
 198. Geller et al., supra note 116, at 1126. The authors excluded studies 
that identified no federal support. In evaluating the articles, researchers noted 
whether race/ethnicity specific results were reported, whether race/ethnicity 
was considered in analyzing the outcomes, and whether the trials recognized 
any limitations on generalizability to broader populations based on race or 
ethnicity. Follow up papers were also examined for any information relating to 
race or ethnicity. Id. at 1124–25. 
 199. Id. at 1127. 
 200. Id. at 1128. The sex-specific OB-GYN studies similarly did not report 
results by race or ethnicity. Id. at 1127. 
 201. Id. at 1130. 
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terms is justified or explained when the research is 
published.202 The researchers’ concern was that using ethno-
racial terms without providing definitions allows the reader to 
infer definitions that may be based on negative stereotypes 
that, in the context of genetic research, reinforce biological 
notions of race.203 The results indicated that race or ethnicity 
terminology was used as a variable in a little more than half 
(51.5%) of the 330 articles reviewed.204 Of the remaining 
articles, approximately half did not include race or ethnicity 
terms at all, while the other half used racial or ethnic 
terminology, but only to identify the study sample, not as a 
variable.205 
Most articles neither explained nor justified the use of the 
particular populations studied.206 Significantly, only 9.1% of 
articles explained how a label was given to a particular 
population, a basic procedure in some journal guidelines, and 
arguably “a basic, easily fulfilled requirement.”207 The authors 
note that the failure to adequately explain the basis for ethno-
racial assignment “impedes constructive use of study 
findings.”208 However, as recent studies of race-related stress 
discussed earlier illustrate, a more thoughtful use of ethno-race 
as descriptor and ascriptor can lead researchers to look more 
 202. Pamela Sankar et al., Race and Ethnicity in Genetic Research 143A 
AM. J. MED. GENETICS 961 (2007). The articles examined in this study show 
that the issue of ensuring clarity and precision in the use of racial and ethnic 
terminology still warrants attention, and “inadequate explanation of the 
meaning and purpose of race and ethnicity is widespread across journals.” Id. 
at 968. 
 203. Id. at 962. 
 204. Id. at 966. 
 205. Id. 
 206. Id. 
 207. Id. 
 208. Id. at 968. Unlike the NIH guidelines, the FDA guidelines do “not 
address the level of participation of racial and ethnic groups in clinical trials” 
nor “establish legally enforceable responsibilities.” U.S. DEP’T OF HEALTH & 
HUM. SERVS., GUIDANCE FOR INDUSTRY: COLLECTION OF RACE AND ETHNICITY 
DATA IN CLINICAL TRIALS 2 (2005), available at 
http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126396.p
df. Rather, the FDA guidelines on the collection of race and ethnicity data are 
actually a series of recommendations to help applicants meet the requirements 
of new drug applications that require subjects to be reported by race, among 
other factors. Logically then, the consequence of failing to follow FDA 
guidelines, or at least failing to collect racial and ethnic data, would be the 
inability to complete a new drug application process. 
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critically at these categories. Nevertheless, researchers still 
need effective guidelines about the use of ethno-race in 
biomedical research that are imposed at the beginning of the 
process. 
The next section of this article offers a tentative two-step 
process for regulating the use of race and ethnicity in 
biomedical research that addresses concerns relating to ethno-
racial inclusion in clinical studies, access to health care, and 
discrimination in treatment, as well as ethno-race related 
disease. The proposed two-step process for a single regulatory 
scheme in federal minority health initiatives would minimize 
researcher confusion and trigger re-education about the use of 
ethno-race in biomedical research. 
 
IV. PROPOSAL FOR REGULATING BIOMEDICAL 
RESEARCH USING RACE/ETHNICITY 
As my friend’s bone density test story illustrates, racial 
identity is ambiguous, even in biomedicine. This section first 
proposes a two-step regulatory scheme that addresses the 
concerns raised in this article about the inappropriate use of 
ethno-race in biomedical research. This proposal is then applied 
to a hypothetical race-related biomedical research proposal. 
A. A PROPOSED REGULATORY SCHEME 
One suggestion Dorothy Roberts makes about using 
funding restrictions to regulate the use of ethno-race in 
biomedical research is that researchers ask themselves 
questions like whether race is being defined biologically or 
socially and whether membership in the racialized group 
“continue[s] to affect health status, access to health care and 
medical treatment” and would thus require “race-conscious 
scientific investigation and legal remedies.”209 While the focus 
of these questions is sound, they do not provide enough 
guidance for reviewers and researchers. Rather, the three 
questions recommended by the Stanford Group are sharper, 
and better suited for incorporation into NIH and other PHS 
funding guidelines.210 
As mentioned previously, the Stanford Group advises 
 209. Roberts, supra note 17, at 531. 
 210. See supra notes 160–166 and accompanying text. 
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researchers when considering ethno-racial categories to ask 
themselves first why race or ethnicity is relevant to the study 
and whether alternative approaches are more appropriate.211 
Addressing this question helps researchers focus on the real 
objective of their study: whether there are differences in bone 
metabolism based on lifestyle. 
Ethno-racial categories, for example, may be perfectly 
acceptable if researchers are assessing health services, but 
even in that situation, given the varied circumstances of black, 
Latino and Asian American subgroups, broad non-descriptive 
terms like black, white, non-white and Asian should be 
avoided. Further, ethno-racial categories may be totally 
inappropriate if studying the correlation between diet and high 
blood pressure. Other factors like socio-economic status, 
geographical location, gender, and family medical history may 
be more accurate and helpful. 
A second question is how race or ethnicity will be 
determined.212 As my foregoing discussion points out, subject 
self-identification as opposed to researcher identification may 
be appropriate if studying access to health care or physician 
bias, but unhelpful when studying the prevalence of certain 
diseases or conditions like sickle cell that are more prevalent in 
certain areas of the world. In that case, looking at subjects’ bio-
geographic ancestry might provide a more useful measure. 
The third question is whether the ethno-racial categories 
are variables in the research.213 Given that ethno-race has 
little if any biological basis, researchers should avoid research 
protocols that use only ethno-racial categories. Thus, ethno-
race should not be used as a variable outside of access to health 
care and treatment. 
These three questions should be threshold inquiries that 
applicants must address in their request for federal funding. 
High impact journals also should ask these same questions 
when researchers submit their findings for publication. As a 
result, there would be a check at both ends of the process with 
funding and publication tied to compliance with these 
guidelines. 
However, the existence of funding guidelines in and of 
 211. Id. 
 212. Id. 
 213. Lee et al., supra note 122, at 404.2. 
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themselves is not enough. As the experience with the Nature 
Genetics publishing guidelines indicates, mandatory guidelines 
may be no more effective than aspirational ones. Thus, 
additional checks are needed. 
One such additional check that should be used is a review 
by a health impact assessment group (HIAG) that would be 
triggered any time a grant applicant’s answers to any of the 
three threshold questions raise the possibility that ethno-race 
will be used as an ascriptive factor. 214 In that instance a multi-
disciplinary HIAG would be convened and charged with 
drafting a health impact assessment (HIA) to “clarify the 
expected health implications of a given action, and of any 
alternatives being considered, for the population groups 
affected by the proposal.”215 
An HIA is a valuable tool to protect against the misuse of 
race in scientific research because it is designed “to clarify 
health implications by disaggregating the determinants of 
health and well-being.”216 In addition, an HIA focuses on 
informed decision-making, and as such, “attempts to identify 
health inequalities that may arise from a proposal.”217 
 214. Information about health impact assessments (HIAs) can be found on 
the World Health Organization website. Health Impact Assessments, WORLD 
HEALTH ORG., http://www.who.int/hia/en/ (last visited Dec. 17, 2010); see also 
R. Quigley et al., Health Impact Assessment: International Best Principles, 
INT’L ASS’N FOR IMPACT ASSESSMENT (2006), 
http://www.iaia.org/publicdocuments/special-publications/SP5.pdf 
(summarizing health impact assessments). 
 215. Nancy Krieger et al., Assessing Health Impact Assessment: 
Multidisciplinary and International Perspectives, 57 J. EPIDEMIOLOGY & 
CMTY. HEALTH 659, 660 (2003) (citing the WORLD HEALTH ORGANISATION, 
REGIONAL OFFICE FOR EUROPE, TECHNICAL BRIEFING: HEALTH IMPACT 
ASSESSMENT—A TOOL TO INCLUDE HEALTH ON THE AGENDA OF OTHER 
SECTORS (2002)). 
 216. Quigley et al., supra note 214, at 2. The determinants of health 
include individual factors, social, environmental, and institutional factors. 
INT’L FINANCE CORP., WORLD BANK GROUP, INTRODUCTION TO HEALTH 
IMPACT ASSESSMENT 7 (2009), available at 
http://www.ifc.org/ifcext/sustainability.nsf/AttachmentsByTitle/p_HealthImpa
ctAssessment/$FILE/HealthImpact.pdf. 
 217. Quigley et al., supra note 214, at 2. The World Health Organization 
identifies several guiding principles of HIAs, including equity, defined as 
“emphasizing the desire to reduce inequity that results from avoidable 
differences in the health determinants and/or health status within and 
between different population groups.” Id. at 3. Another guiding principle, the 
ethical use of evidence, focuses on ensuring that “the best available evidence 
from different disciplines and methodologies is utilized, that all evidence is 
valued, and that recommendations are developed impartially.” Id. 
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Legal scholar Osagie K. Obasogie proposed a similar 
impact assessment mechanism that he calls a racial impact 
assessment, as a regulatory tool to prevent new biotechnologies 
from advancing unsubstantiated notions of biological race.218 
Although he uses the FDA approval process as an example of 
when race impact assessments would be appropriate, Obasogie 
notes that this process may still be useful in other contexts.219 
The value of race impact assessments, according to Obasogie, is 
the shared responsibility between “regulators, researchers, 
internal review boards, and affected communities and their 
representatives.”220 My proposal expands on Obasogie’s idea, 
applying it to biomedical research in general and providing a 
more detailed example below of how the assessment impact 
would work. 
B. APPLYING THE PROPOSED STANDARD: BONE DENSITY 
STUDIES REVISITED 
This section explains how the two-step process I outlined in 
the prior section might work in real life. Suppose researchers 
submitted a grant proposal seeking federal funding for a study 
examining whether racial differences in bone density between 
blacks and whites can be explained by differences in bone 
metabolism and lifestyle.221 The researchers propose to study a 
cohort of roughly equal numbers of women and men, black and 
 218. Obasogie, supra note 28, at 496. As an example, Obasogie proposes an 
FDA advisory committee ‘as part of its review process to evaluate whether 
medicines like BiDil might reinforce biological understandings of race when no 
biological or genetic mechanism has been identified. OBASOGIE, GENE CARD, 
supra note 24, at 47. Obasogie’s recommendation is equally workable for 
biomedical research. The ultimate goal in both instances is to “increase the 
dialogue between stakeholders and policymakers so as to balance competing 
interests through strategic planning that promotes public good.” Id. 
 219. Obasogie also suggests race impact assessments in evaluating 
marketing of ancestry tests and the effects of DNA forensics on certain 
communities. OBASOGIE, GENE CARD, supra note 24, at 47. 
220 Id. at 46. 
 221. For just such a study see Bruce Ettinger et al., Racial Differences in 
Bone Density Between Young Adult Black and White Subjects Persist after 
Adjustment for Anthropometric, Lifestyle, and Biochemical Differences, 82 J. 
CLIN. ENDOCRINOLOGY & METABOLISM 429 (1997). This study was supported 
in part by the National Institute of Health & Human Services. Id. The 
researchers conclude that “the appearance of . . . large racial difference in 
young adults cannot be attributed to persistent differences in metabolic or 
lifestyle factors and supports the view that bone density differences result 
from influences operating during childhood and adolescence.” Id. at 434. 
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white, between the ages of 25-36 years.222 
Other than reporting ethno-race to comply with federal 
regulations designed to ensure greater access to clinical trials 
by ethno-racial minorities, other use of ethno-race 
automatically would be suspect.223 If ethno-racial categories 
are to be used for other purposes, researchers must explain 
why these categories are relevant. Thus the researchers in the 
hypothetical would need to explain why race is relevant in their 
study. They might justify the use of ethno-racial categories to 
examine the validity of earlier studies that found differences in 
bone density between whites and blacks saying that they are 
trying to determine whether these differences reflect lifestyle 
rather than racial differences. 
As my foregoing discussion indicates, this justification 
suggests that race would be used ascriptively and thus 
inappropriately. At this stage, the second step of my proposal, 
an HIA, would likely be triggered. HIAG members might 
discuss whether the proposed use of ethno-race in the study 
tends to reinforce biological understandings of race when no 
biological or genetic mechanism has been identified. If so, the 
HIAG members might require that the researchers reconsider 
the proposed use of ethno-race or they will withhold funding 
until the researchers modify their protocol so that ethno-racial 
categories are eliminated or used appropriately. 
Assuming the researchers can satisfactorily explain the 
relevance of race in their proposed study, the next inquiry 
would be how the subjects’ race would be determined for 
biomedical research as opposed to federal reporting purposes. 
Consider again the problem with determining the racial 
classification of the clinical subject mentioned earlier who self-
identifies as Cape Verdean. This is a question Braun and her 
co-authors address.224 Their response is that this individual 
defies conventional census-related racial classification for 
 222. Id. at 430. The researchers also excluded “for certain laboratory 
abnormalities and pregnancy-related criteria . . . . breast-feeding women” and 
women currently using oral contraceptives. Id. 
 223. As mentioned previously, federal regulations require that researchers 
use a universal standard, the OMB ethno-racial categories, in reporting the 
diversity of the research study subject population. The use of OMB ethno-
racial categories is used in the regulations as a way of guarding against past 
exclusionary practices, but these categories are insufficiently precise for 
biomedical purposes, even in access to health care studies. See Braun et al., 
supra note 15, at 1424. 
 224. Id. 
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biomedical purposes.225 If the researchers’ proposed method for 
identifying the race of clinical subjects in this case seems 
inappropriate, an HIA could again be triggered at this point. 
HIAG members might suggest other approaches. One 
possible approach in determining the ethno-race of a clinical 
subject might be to supplement the detailed subject self-
identification collected for reporting purposes with a 
questionnaire to ascertain a subject’s bio-geographical ancestry. 
Thus if my friend, for example, was a subject, she might self-
identify as black or African American (as opposed to black 
Caribbean or black South African or Afro-Cuban or bi/multi-
racial). The supplemental questionnaire would ask more 
detailed information about bio-geographic ancestry, where she 
was raised and currently resides. 
This additional information would help separate recent 
immigrants from native-born Americans, perhaps an important 
variable in some studies and would naturally lead to an 
examination of the answer to the third question, whether 
ethno-race is used as a variable in the research. Under the 
Stanford Group standard, ethno-race should not be used as a 
variable outside of studies of access to health care and 
treatment.226 Thus if the research protocol indicates that 
research would be used in another context, this as well would 
trigger an HIA. 
Concededly an HIA inquiry can be a costly and labor-
intensive mechanism to protect against the inappropriate use 
of ethno-race in biomedical research. But without rigorous 
guidelines like the ones I propose, researchers will continue “to 
use these same variables in the subsequent analysis and 
theoretical framing of the research.”227 Hopefully, HIA 
inquiries will be temporary measures that can be useful in 
helping federal funding agencies develop more substantial 
guidelines as they gain more experience reviewing individual 
protocols. 
It must again be noted, however, that better federal 
guidelines alone will be insufficient to remedy the problem I 
 225. “In clinical research projects or in the clinic, the assignment of race 
assumes an equivalence between census categories and genetics embodied by 
patients. . . . We suggest that, as with Cape Verdeans, census race cannot be 
assumed to reflect a particular genetic make-up.” Id. 
 226. Lee et al. supra note 122, at 404.2. 
 227. Braun et al., supra note 15, at 1424. 
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have described. My suggestions are just a first step in changing 
the way the medical community thinks about ethno-race. The 
importance of better biology education, starting in high school, 
is also essential in addressing the tendency to misuse ethno-
race in biomedical research.228 
V. CONCLUSION 
It is clear that changing how medical research 
communities think about race will be difficult. Researchers, 
many of whom are affiliated with medical schools, continue to 
use outdated and inaccurate notions about the validity of racial 
and ethnic differences in medical research unrelated to 
healthcare access and provider treatment bias. These 
researchers transmit their biases to their students replicating 
the problematic use of ethno-race in medical research and 
practice. 
As my friend’s experience with her bone density test 
illustrates, health care providers, like biomedical researchers, 
also continue to rely, often unthinkingly, on socially 
constructed racial categories in treatment and diagnosis, often 
to the detriment of ethnic and racial minorities.229 I know this 
from personal experience. In 1983 my daughter’s pediatrician 
suspected she had Crohn’s Disease and required 
hospitalization. But upon her admission to Texas Children’s 
Hospital in Houston the pediatric gastroenterologist, one of the 
best in the nation, resisted this diagnosis, telling me that 
Crohn’s Disease was found in “middle-class Jewish children,” 
not black children. It took ten days of testing before the 
gastroenterologist agreed with the pediatrician’s initial 
diagnosis. 
It is important to determine the validity of ethno-racial 
 228. Braun and her co-authors write:  
Improved medical training about race can sharpen diagnostic skills. 
Cultural competency instruction should be modified to include 
information on the history of racial categories, current controversies 
about their biological significance, and the limits of their utility. A 
teaching unit on race would also contrast the differences between race 
as a population concept with its meaning when applied to the lives of 
individuals. In this context it would be appropriate to teach about 
geographical variations in specific allele frequencies for genes linked 
to particular disease processes, as well as the cultural practices, 
historical trends, and environmental conditions that favor their 
prevalence or not. 
Braun et al., supra note 15, at 1426–27. 
 229. Roberts, supra note 17, at 531. 
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classifications in each setting. In medicine, as in other areas, 
ethno-race is so powerful that it tends to shout, drowning out 
other explanations for adverse health outcomes. As Troy Duster 
explains “[t]he task is to determine how the social meaning of 
race can affect biological outcomes.”230 Mandatory funding 
guidelines that require researchers to think more critically 
about any proposed use of ethno-race in biomedical research is 
one important mechanism government should use to discourage 
inappropriate use of ethno-racial categories in biomedical 
research and ultimately the medical treatment of all 
Americans. 
 
 230. Troy Duster, Buried Alive: The Concept of Race in Science, CHRON. 
HIGHER EDUC., Sept. 14, 2001 at B12. See also Pilar Ossorio & Troy Duster, 
Race and Genetics: Controversies in Biomedical, Behavioral, and Forensic 
Sciences, 60 AM. PSYCHOLOGIST 115, 116 (2005). 
